Drug Name,Active Ingredient,Form; Route,Date,URL
abacavir and lamivudine,abacavir sulfate;lamivudine,TABLET;ORAL,12/22/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204311s000lbl.pdf#page=34
abilify,aripiprazole,SOLUTION;ORAL,02/05/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
abilify,aripiprazole,"TABLET, ORALLY DISINTEGRATING;ORAL",02/05/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
abilify,aripiprazole,TABLET;ORAL,11/30/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021436s048lbl.pdf#page=47
abilify,aripiprazole,INJECTABLE;INTRAMUSCULAR,02/05/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
abilify maintena kit,aripiprazole,"FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR",02/05/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf#page=52
abilify mycite kit,aripiprazole,TABLET;ORAL,11/30/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207202s006lbl.pdf#page=64
abrilada,adalimumab-afzb,INJECTABLE;INJECTION,10/04/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761118s007lbl.pdf#page=47
absorica,isotretinoin,CAPSULE;ORAL,07/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021951s013lbl.pdf#page=32
abstral,fentanyl citrate,TABLET;SUBLINGUAL,10/07/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022510s018lbl.pdf#page=29
accutane,isotretinoin,CAPSULE;ORAL,10/22/2010,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s061MedGuide.pdf
aciphex,rabeprazole sodium,"TABLET, DELAYED RELEASE;ORAL",07/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020973s043lbl.pdf#page=34
aciphex sprinkle,rabeprazole sodium,"CAPSULE, DELAYED RELEASE;ORAL",11/27/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204736s012lbl.pdf#page=21
actemra,tocilizumab,INJECTABLE; INJECTION,09/20/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125276s144,125472s056lbl.pdf#page=55"
actemra,tocilizumab,"INJECTABLE;INTRAVENOUS, SUBCUTANEOUS",09/20/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125276s144,125472s056lbl.pdf#page=55"
acthar gel,corticotropin,INJECTABLE;INJECTION,02/29/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/008372s071lbl.pdf#page=17
actiq,fentanyl citrate,TROCHE/LOZENGE;TRANSMUCOSAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020747s062lbl.pdf#page=44
actonel,risedronate sodium,TABLET;ORAL,11/05/2019,http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf#page=38
actonel with calcium (copackaged),calcium carbonate; risedronate sodium,TABLET;ORAL,04/08/2015,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021823s011lbl.pdf#page=27
actoplus met,metformin hydrochloride; pioglitazone hydrochloride,TABLET;ORAL,12/21/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021842s022lbl.pdf#page=41
actoplus met xr,metformin hydrochloride; pioglitazone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",12/21/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022024s014lbl.pdf#page=41
actos,pioglitazone hydrochloride,TABLET;ORAL,12/21/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf#page=35
adasuve,loxapine,POWDER;INHALATION,02/01/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022549s010lbl.pdf#page=28
adderall 10,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,TABLET;ORAL,10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15
adderall 12.5,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,TABLET;ORAL,10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15
adderall 15,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,TABLET;ORAL,10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15
adderall 20,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,TABLET;ORAL,10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15
adderall 30,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,TABLET;ORAL,02/25/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15
adderall 5,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,TABLET;ORAL,02/25/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15
adderall 7.5,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,TABLET;ORAL,02/25/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15
adderall xr 10,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22
adderall xr 15,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22
adderall xr 20,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22
adderall xr 25,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s038lbl.pdf#page=22
adderall xr 30,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,"CAPSULE, EXTENDED RELEASE;ORAL",07/03/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24
adderall xr 5,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,"CAPSULE, EXTENDED RELEASE;ORAL",07/03/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24
addyi,flibanserin,TABLET;ORAL,09/29/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022526s009lbl.pdf#page=23
adempas,riociguat,TABLET;ORAL,09/10/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf#page=24
adhansia xr,methylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",06/28/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212038s002lbl.pdf#page=25
adlyxin,lixisenatide,SOLUTION;SUBCUTANEOUS,09/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208471s007lbl.pdf#page=24
aduhelm,aducanumab-avwa,INJECTABLE; INJECTION,08/30/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761178s011lbl.pdf#page=26
adzenys er,amphetamine,"SUSPENSION, EXTENDED RELEASE;ORAL",02/25/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204325s003lbl.pdf#page=26
adzenys xr-odt,amphetamine,"TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL",03/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204326s011lbl.pdf#page=27
afrezza,insulin recombinant human,POWDER;INHALATION,02/03/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022472s023lbl.pdf#page=19
alkindi sprinkle,hydrocortisone,GRANULE;ORAL,06/05/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213876s002lbl.pdf#page=14
alvaiz,eltrombopag choline,TABLET;ORAL,11/29/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216774s000lbl.pdf#page=30
ambien,zolpidem tartrate,TABLET;ORAL,02/23/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf#page=24
ambien cr,zolpidem tartrate,"TABLET, EXTENDED RELEASE;ORAL",02/23/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf#page=27
amjevita,adalimumab-atto,INJECTABLE;INJECTION,08/14/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761024s015lbl.pdf#page=50
ampyra,dalfampridine,"TABLET, EXTENDED RELEASE;ORAL",11/18/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf#page=13
anafranil,clomipramine hydrochloride,CAPSULE;ORAL,05/10/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019906s043lbl.pdf#page=27
anaprox,naproxen sodium,TABLET;ORAL,11/21/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
anaprox ds,naproxen sodium,TABLET;ORAL,05/13/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf#page=23"
androgel,testosterone,"GEL, METERED;TRANSDERMAL",05/30/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf#page=25
androgel,testosterone,GEL;TRANSDERMAL,05/30/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf#page=25
androgel,testosterone,GEL;TRANSDERMAL,05/30/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf#page=23
androgel,testosterone,"GEL, METERED;TRANSDERMAL",05/30/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf#page=23
ansaid,flurbiprofen,TABLET;ORAL,05/09/2016,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018766s015MedGuide.pdf
apadaz,acetaminophen; benzhydrocodone hydrochloride,TABLET;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208653s008lbl.pdf#page=40
aplenzin,bupropion hydrobromide,"TABLET, EXTENDED RELEASE;ORAL",05/07/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022108s022lbl.pdf#page=29
aptensio xr,methylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205831s008lbl.pdf#page=19
aptiom,eslicarbazepine acetate,TABLET;ORAL,03/15/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf#page=25
aptryxol,desvenlafaxine,"TABLET,EXTENDED RELEASE;ORAL",08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205583s014lbl.pdf#page=30
aranesp,darbepoetin alfa,VIAL; INTRAVENOUS,01/30/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25
aranesp,darbepoetin alfa,VIAL; SUBCUTANEOUS,01/30/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25
arcapta neohaler,indacaterol maleate,POWDER;INHALATION,07/30/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022383s000MedG.pdf
arikayce kit,amikacin sulfate,"SUSPENSION, LIPOSOMAL;INHALATION",02/10/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207356s004lbl.pdf#page=15
aristada,aripiprazole lauroxil,"SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR",03/30/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=36"
aristada initio kit,aripiprazole lauroxil,"SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR",03/30/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=72"
arthrotec,diclofenac sodium; misoprostol,"TABLET, DELAYED RELEASE;ORAL",11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020607s043lbl.pdf#page=33
arymo er,morphine sulfate,"TABLET, EXTENDED RELEASE;ORAL",10/07/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208603s005lbl.pdf#page=34
astagraf xl,tacrolimus,"CAPSULE, EXTENDED RELEASE;ORAL",11/22/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf#page=91"
astagraf xl,tacrolimus,"CAPSULE, EXTENDED RELEASE;ORAL",09/14/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf#page=91"
astagraf xl,tacrolimus,"CAPSULE, EXTENDED RELEASE;ORAL",09/14/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210115s006lbl.pdf#page=33
astagraf xl,tacrolimus,"CAPSULE, EXTENDED RELEASE;ORAL",09/14/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204096s011lbl.pdf#page=33
atelvia,risedronate sodium,"TABLET, DELAYED RELEASE;ORAL",08/18/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf#page=24
ativan,lorazepam,TABLET;ORAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf#page=14
aubagio,teriflunomide,TABLET;ORAL,06/10/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202992s013s015lbl.pdf#page=25
austedo,deutetrabenazine,TABLET;ORAL,05/29/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216354s000lbl.pdf#page=29
austedo,deutetrabenazine,TABLET;ORAL,11/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208082s016s017lbl.pdf#page=29
auvelity,bupropion; dextromethorphan,"TABLET, EXTENDED RELEASE; ORAL",05/07/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215430s000lblCorrect3.pdf#page=25
avandamet,metformin hydrochloride; rosiglitazone maleate,TABLET;ORAL,04/05/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021410s040lbl.pdf#page=38
avandaryl,glimepiride; rosiglitazone maleate,TABLET;ORAL,04/27/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217006s000lbl.pdf#page=39
avandia,rosiglitazone maleate,TABLET;ORAL,02/05/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021071s052lbl.pdf#page=38
aveed,testosterone undecanoate,INJECTABLE;INTRAMUSCULAR,08/16/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022219s014lbl.pdf#page=23
avelox,moxifloxacin hydrochloride,TABLET;ORAL,05/06/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33"
avelox in sodium chloride 0.8% in plastic container,moxifloxacin hydrochloride,SOLUTION;INTRAVENOUS,05/06/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33"
avinza,morphine sulfate,"CAPSULE, EXTENDED RELEASE;ORAL",06/26/2015,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311346.pdf
avonex,interferon beta-1a,VIAL,07/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103628s5269lbl.pdf#page=22
avsola,infliximab-axxq,INJECTABLE;INJECTION,09/09/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761086s000lbl.pdf#page=48
axiron,testosterone,"SOLUTION, METERED;TRANSDERMAL",07/13/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022504s016lbl.pdf#page=15
azstarys,dexmethylphenidate hydrochloride; serdexmethylphenidate chloride,CAPSULE;ORAL,10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212994s000lbl.pdf#page=26
banzel,rufinamide,SUSPENSION;ORAL,05/30/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201367Orig1s011lbl.pdf#page=19
banzel,rufinamide,TABLET;ORAL,11/28/2019,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf#page=19"
bavencio,avelumab,INJECTABLE;INJECTION,11/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761049s020lbl.pdf#page=36
bavencio,avelumab,INJECTABLE;INTRAVENOUS,05/09/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761078s000lbl.pdf#page=23
baxdela,delafloxacin meglumine,TABLET;ORAL,06/19/2017,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf#page=28"
baxdela,delafloxacin meglumine,POWDER;INTRAVENOUS,12/01/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208611s007lbl.pdf#page=28
belbuca,buprenorphine hydrochloride,FILM;BUCCAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207932s023lbl.pdf#page=40
belsomra,suvorexant,TABLET;ORAL,03/25/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204569s008lbl.pdf#page=23
benlysta,belimumab,INJECTABLE;INJECTION,05/16/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125370s079,761043s022lbl.pdf#page=41"
benlysta,belimumab,INJECTABLE; INJECTION,05/16/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125370s079,761043s022lbl.pdf#page=41"
besremi,ropeginterferon alfa-2b-njft,INJECTABLE;SUBCUTANEOUS,04/29/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761166s000lbl.pdf#page=18
betaseron,interferon beta-1b,VIAL; SUBCUTANEOUS,07/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103471s5202lbl.pdf#page=19
bevyxxa,betrixaban,CAPSULE;ORAL,08/24/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf#page=20
bimzelx,bimekizumab-bkzx,INJECTABLE; SUBCUTANEOUS,09/20/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761151s005s006s007lbl.pdf#page=29
binosto,alendronate sodium,"TABLET, EFFERVESCENT;ORAL",10/13/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202344s008lbl.pdf#page=33
blenrep,belantamab mafodotin-blmf,INJECTABLE;INTRAVENOUS,02/28/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761158s006lbl.pdf#page=22
blincyto,blinatumomab,INJECTABLE;INJECTION,06/14/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125557s023s026lbl.pdf#page=41
boniva,ibandronate sodium,INJECTABLE;INTRAVENOUS,01/11/2022,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf#page=18
boniva,ibandronate sodium,TABLET;ORAL,12/07/2016,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf#page=19
bonsity,teriparatide,SOLUTION;SUBCUTANEOUS,11/16/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211939s004lbl.pdf#page=23
botox,onabotulinumtoxina,VIAL; SINGLE-USE,08/10/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103000s5327lbl.pdf#page=49
botox cosmetic,onabotulinumtoxina,VIAL; SINGLE-USE,08/10/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103000s5327lbl.pdf#page=49
braftovi,encorafenib,CAPSULE;ORAL,09/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210496s016lbl.pdf#page=31
brenzavvy,bexagliflozin,TABLET;ORAL,09/12/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s001lbl.pdf#page=22
brexafemme,ibrexafungerp,TABLET;ORAL,11/30/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214900s002lbl.pdf#page=18
brilinta,ticagrelor,TABLET;ORAL,03/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022433s034lbl.pdf#page=35
brisdelle,paroxetine mesylate,CAPSULE;ORAL,08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204516s013lbl.pdf#page=18
briumvi,ublituximab-xiiy,INJECTABLE;INJECTION,12/28/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761238s000lbl.pdf#page=18
briviact,brivaracetam,SOLUTION;INTRAVENOUS,05/17/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf#page=18"
briviact,brivaracetam,SOLUTION;ORAL,05/17/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf#page=18"
briviact,brivaracetam,TABLET;ORAL,05/17/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205836s014,205837s011,205838s011lbl.pdf#page=18"
brixadi,buprenorphine,"INJECTION, EXTENDED RELEASE;SUBCUTANEOUS",05/23/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210136s000lbl.pdf#page=52
brovana,arformoterol tartrate,SOLUTION;INHALATION,05/29/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021912s013lbl.pdf#page=22
bunavail,buprenorphine hydrochloride; naloxone hydrochloride,FILM;BUCCAL,06/17/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205637s023s024lbl.pdf#page=33
butrans,buprenorphine,"FILM, EXTENDED RELEASE;TRANSDERMAL",12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021306s041lbl.pdf#page=45
bydureon,exenatide synthetic,"FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS",12/21/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022200s034lbl.pdf#page=37
bydureon bcise,exenatide synthetic,"SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS",03/06/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209210s022lbl.pdf#page=36
bydureon pen,exenatide synthetic,"FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS",12/21/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022200s034lbl.pdf#page=37
byetta,exenatide synthetic,INJECTABLE;SUBCUTANEOUS,12/21/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021773s048lbl.pdf#page=33
byetta,exenatide synthetic,INJECTABLE; SUBCUTANEOUS,10/30/2009,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191084.pdf
cambia,diclofenac potassium,FOR SOLUTION;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022165s016lbl.pdf#page=22
camzyos,mavacamten,CAPSULE;ORAL,06/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214998s001lbl.pdf#page=29
caplyta,lumateperone tosylate,CAPSULE;ORAL,06/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209500s011lbl.pdf#page=22
caprelsa,vandetanib,TABLET;ORAL,03/28/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022405s019lbl.pdf#page=20
carbatrol,carbamazepine,"CAPSULE, EXTENDED RELEASE;ORAL",04/11/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf#page=23
cassipa,buprenorphine hydrochloride; naloxone hydrochloride,FILM;SUBLINGUAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208042s011lbl.pdf#page=30
cataflam,diclofenac potassium,TABLET;ORAL,04/28/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020142s029lbl.pdf#page=19
celebrex,celecoxib,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf#page=41
celebrex,celecoxib,CAPSULE;ORAL,02/04/2011,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020998s033,021156s003MedG.pdf"
celexa,citalopram hydrobromide,SOLUTION;ORAL,12/03/2012,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020822s042,021046s019lbl.pdf#page=32"
celexa,citalopram hydrobromide,TABLET;ORAL,08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020822s054lbl.pdf#page=22
cellcept,mycophenolate mofetil,CAPSULE;ORAL,08/10/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39"
cellcept,mycophenolate mofetil,TABLET;ORAL,08/10/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39"
cellcept,mycophenolate mofetil hydrochloride,INJECTABLE;INJECTION,08/10/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39"
cellcept,mycophenolate mofetil,FOR SUSPENSION;ORAL,08/10/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39"
celontin,methsuximide,CAPSULE;ORAL,06/15/2011,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229201.pdf
cerdelga,eliglustat tartrate,CAPSULE;ORAL,08/29/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf#page=19
chantix,varenicline tartrate,TABLET;ORAL,02/22/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021928s048lbl.pdf#page=22
chlordiazepoxide and amitriptyline hydrochloride,amitriptyline hydrochloride; chlordiazepoxide,TABLET;ORAL,02/05/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/071297Orig1s026MG.pdf
cibinqo,abrocitinib,TABLET; ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213871s004lblcorrected.pdf#page=27
cimzia,certolizumab pegol,INJECTABLE; INJECTION,09/13/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125160s275lbl.pdf#page=42
cipro,ciprofloxacin hydrochloride,TABLET;ORAL,09/20/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf#page=40"
cipro,ciprofloxacin,INJECTABLE;INJECTION,03/25/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019847s063lbl.pdf#page=33
cipro,ciprofloxacin,FOR SUSPENSION;ORAL,09/20/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf#page=40"
cipro in dextrose 5% in plastic container,ciprofloxacin,INJECTABLE;INJECTION,03/25/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019857s073lbl.pdf#page=33
cipro xr,ciprofloxacin; ciprofloxacin hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",03/30/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021473s043lbl.pdf#page=30
citalopram,citalopram hydrobromide,CAPSULE; ORAL,08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215428s002lbl.pdf#page=24
clenpiq,citric acid; magnesium oxide; sodium picosulfate,SOLUTION;ORAL,08/29/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209589s015lbl.pdf#page=14
clinoril,sulindac,TABLET;ORAL,12/23/2010,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088573.pdf
codeine sulfate,codeine sulfate,SOLUTION;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202245s010lbl.pdf#page=30
codeine sulfate,codeine sulfate,TABLET;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022402s015lbl.pdf#page=29
colcrys,colchicine,TABLET;ORAL,05/14/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022352s026lbl.pdf#page=25
colcrys,colchicine,TABLET; ORAL,10/16/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022353lbl.pdf#page=19
columvi,glofitamab-gxbm,INJECTABLE;INTRAVENOUS,06/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761309s000lbl.pdf#page=19
combogesic,acetaminophen; ibuprofen,TABLET;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209471s001lbl.pdf#page=28
combunox,ibuprofen; oxycodone hydrochloride,TABLET;ORAL,09/02/2010,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021378s006lbl.pdf#page=30
concerta,methylphenidate hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021121s049lbl.pdf#page=30
consensi,amlodipine besylate; celecoxib,TABLET;ORAL,04/28/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210045s009lbl.pdf#page=10
contrave,bupropion hydrochloride; naltrexone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",05/07/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200063s021lbl.pdf#page=40
conzip,tramadol hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022370s025lbl.pdf#page=37
copegus,ribavirin,TABLET;ORAL,08/11/2015,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021511s029lbl.pdf#page=27
copiktra,duvelisib,CAPSULE;ORAL,12/17/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211155s005lbl.pdf#page=28
cordarone,amiodarone hydrochloride,TABLET;ORAL,10/17/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf#page=13
corlanor,ivabradine hydrochloride,TABLET;ORAL,08/04/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24"
corlanor,ivabradine,SOLUTION;ORAL,08/04/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24"
cosentyx,secukinumab,"INJECTABLE;SUBCUTANEOUS, INTRAVENOUS",10/06/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761349s000lbl.pdf#page=32
cosentyx,secukinumab,INJECTABLE;INJECTION,08/16/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125504s082lbl.pdf#page=33
cotempla xr-odt,methylphenidate,"TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205489s012lbl.pdf##page=24
coumadin,warfarin sodium,INJECTABLE;INJECTION,08/14/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30
coumadin,warfarin sodium,TABLET;ORAL,08/14/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30
coxanto,oxaprozin,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217927s002lbl.pdf#page=24
creon,pancrelipase (amylase;lipase;protease),"CAPSULE, DELAYED RELEASE;ORAL",06/02/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020725s028lbl.pdf#page=16
cyltezo,adalimumab-adbm,INJECTABLE;INJECTION,04/30/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761058s018lbl.pdf#page=38
cymbalta,duloxetine hydrochloride,"CAPSULE, DELAYED REL PELLETS;ORAL",08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf#page=38
daliresp,roflumilast,TABLET;ORAL,01/23/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022522s009lbl.pdf#page=17
dalmane,flurazepam hydrochloride,CAPSULE;ORAL,03/27/2009,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016721s077lbl.pdf
darvocet-n 100,acetaminophen; propoxyphene napsylate,TABLET;ORAL,09/25/2009,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf
darvocet-n 50,acetaminophen; propoxyphene napsylate,TABLET;ORAL,09/25/2009,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf
darvon,propoxyphene hydrochloride,CAPSULE;ORAL,09/25/2009,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf
darvon-n,propoxyphene napsylate,TABLET;ORAL,09/25/2009,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf
daurismo,glasdegib maleate,TABLET;ORAL,03/27/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210656s005lbl.pdf#page=20
daxxify,daxibotulinumtoxina-lanm,INJECTABLE;INTRAMUSCULAR,08/11/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761127s002lbl.pdf#page=16
daypro,oxaprozin,TABLET;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018841s036lbl.pdf#page=25
daypro alta,oxaprozin potassium,TABLET;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020776s013lbl.pdf#page=22
daytrana,methylphenidate,SYSTEM;TRANSDERMAL,11/29/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021514s039lbl.pdf#page=24
daytrana,methylphenidate,"FILM, EXTENDED RELEASE;TRANSDERMAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021514s036lbl.pdf#page=25
dayvigo,lemborexant,TABLET;ORAL,04/20/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212028s008lbl.pdf#page=22
demerol,meperidine hydrochloride,TABLET;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005010s060lbl.pdf#page=31
demerol,meperidine hydrochloride,INJECTABLE;INJECTION,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005010s060lbl.pdf#page=31
demerol,meperidine hydrochloride,SYRUP;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005010s060lbl.pdf#page=31
depakene,valproic acid,CAPSULE;ORAL,05/19/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018081s070,018082s053lbl.pdf#page=41"
depakene,valproic acid,SYRUP;ORAL,05/19/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018081Orig1s068%20018082Orig1s051lbl.pdf#page=38
depakote,divalproex sodium,"CAPSULE, DELAYED REL PELLETS;ORAL",03/18/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019680s052lbl.pdf#page=42
depakote,divalproex sodium,"TABLET, DELAYED RELEASE;ORAL",03/18/2024,http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018723s066lbledt.pdf#page=48
depakote er,divalproex sodium,"TABLET, EXTENDED RELEASE;ORAL",03/18/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021168s044lbl.pdf#page=48
descovy,emtricitabine; tenofovir alafenamide fumarate,TABLET;ORAL,01/07/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208215s019lbl.pdf#page=37
desoxyn,methamphetamine hydrochloride,TABLET;ORAL,10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005378s038lbl.pdf#page=12
desoxyn,methamphetamine hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",09/24/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/005378s032lbl.pdf#page=17
desvenlafaxine,desvenlafaxine fumarate,"TABLET, EXTENDED RELEASE;ORAL",07/18/2014,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205208Orig1s001lbl.pdf#page=23
desvenlafaxine,desvenlafaxine,"TABLET, EXTENDED RELEASE;ORAL",08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204150s020lbl.pdf#page=33
desyrel,trazodone hydrochloride,TABLET;ORAL,10/18/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf#page=13
desyrel,trazodone hydrochloride,TABLET;ORAL,10/18/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018207s033lbl.pdf#page=14
dexedrine,dextroamphetamine sulfate,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017078s055lbl.pdf#page=14
dexilant,dexlansoprazole,"CAPSULE, DELAYED RELEASE;ORAL",07/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s038lbl.pdf#page=24
dextroamphetamine sulfate,dextroamphetamine sulfate,SOLUTION;ORAL,01/04/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/40776MG.pdf#page=7
diacomit,stiripentol,CAPSULE;ORAL,08/20/2018,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17"
diacomit,stiripentol,FOR SUSPENSION;ORAL,08/20/2018,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17"
dilantin,phenytoin sodium,CAPSULE;ORAL,09/07/2022,http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf#page=21
dilantin,phenytoin,"TABLET, CHEWABLE;ORAL",10/22/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/084427s039s041lbl.pdf#page=17
dilantin-125,phenytoin,SUSPENSION;ORAL,03/03/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf#page=19
dilantin-30,phenytoin,SUSPENSION;ORAL,03/03/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf#page=19
dilaudid,hydromorphone hydrochloride,SOLUTION;ORAL,12/15/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf#page=32"
dilaudid,hydromorphone hydrochloride,TABLET;ORAL,12/15/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf#page=32"
dolophine hydrochloride,methadone hydrochloride,SYRUP;ORAL,06/02/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/006134s050lbl.pdf#page=36
dolophine hydrochloride,methadone hydrochloride,TABLET;ORAL,06/02/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/006134s050lbl.pdf#page=36
doral,quazepam,TABLET;ORAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf#page=11
dotarem,gadoterate meglumine,SOLUTION;INTRAVENOUS,01/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204781s012lbl.pdf#page=17
drizalma sprinkle,duloxetine hydrochloride,"CAPSULE, DELAYED REL PELLETS;ORAL",08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212516s005lbl.pdf#page=45
droxia,hydroxyurea,CAPSULE;ORAL,11/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf#page=16
duetact,glimepiride; pioglitazone hydrochloride,TABLET;ORAL,12/21/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021925s017lbl.pdf#page=39
duexis,famotidine; ibuprofen,TABLET;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022519s014lbl.pdf#page=25
duragesic-100,fentanyl,"FILM, EXTENDED RELEASE;TRANSDERMAL",03/04/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52
duragesic-12,fentanyl,"FILM, EXTENDED RELEASE;TRANSDERMAL",03/04/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52
duragesic-25,fentanyl,"FILM, EXTENDED RELEASE;TRANSDERMAL",03/04/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52
duragesic-37,fentanyl,"FILM, EXTENDED RELEASE;TRANSDERMAL",03/04/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52
duragesic-50,fentanyl,"FILM, EXTENDED RELEASE;TRANSDERMAL",03/04/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52
duragesic-75,fentanyl,"FILM, EXTENDED RELEASE;TRANSDERMAL",03/04/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52
duzallo,allopurinol; lesinurad,TABLET;ORAL,08/18/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209203s000lbl.pdf#page=27
dyanavel xr,amphetamine,"SUSPENSION, EXTENDED RELEASE;ORAL",10/13/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"
dyanavel xr 10,amphetamine; amphetamine aspartate/dextroamphetamine sulfate,"TABLET, EXTENDED RELEASE;ORAL",10/13/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"
dyanavel xr 15,amphetamine; amphetamine aspartate/dextroamphetamine sulfate,"TABLET, EXTENDED RELEASE;ORAL",10/13/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"
dyanavel xr 20,amphetamine; amphetamine aspartate/dextroamphetamine sulfate,"TABLET, EXTENDED RELEASE;ORAL",10/13/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"
dyanavel xr 5,amphetamine; amphetamine aspartate/dextroamphetamine sulfate,"TABLET, EXTENDED RELEASE;ORAL",10/13/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208147s016,210526s008lbl.pdf#page=21"
dysport,abobotulinumtoxina,INJECTABLE; INJECTION,09/21/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125274s125lbl.pdf#page=30
ec-naprosyn,naproxen,"TABLET, DELAYED RELEASE;ORAL",11/21/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
edluar,zolpidem tartrate,TABLET;SUBLINGUAL,08/18/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021997s011lbl.pdf#page=23
effexor,venlafaxine hydrochloride,TABLET;ORAL,12/12/2012,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020151s031s055s058s060lbl.pdf#page=34
effexor xr,venlafaxine hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf#page=41
effient,prasugrel hydrochloride,TABLET;ORAL,12/22/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022307s018lbl.pdf#page=21
elepsia xr,levetiracetam,"TABLET, EXTENDED RELEASE;ORAL",03/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204417s004lbl.pdf#page=25
elidel,pimecrolimus,CREAM;TOPICAL,06/09/2016,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088587.pdf
eliquis,apixaban,TABLET;ORAL,10/12/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202155s034lbl.pdf#page=38
elmiron,pentosan polysulfate sodium,CAPSULE;ORAL,03/12/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020193s015lbl.pdf#page=11
elrexfio,elranatamab-bcmm,INJECTABLE; SUBCUTANEOUS,08/14/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761345s000lbl.pdf#page=22
elucirem,gadopiclenol,INJECTABLE;INTRAVENOUS,01/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216986s000lbl.pdf#page=17
elyxyb,celecoxib,SOLUTION;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212157s003lbl.pdf#page=26
embeda,morphine sulfate; naltrexone hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",10/07/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022321s030lbl.pdf#page=30
empavel,pegcetacoplan,INJECTABLE;SUBCUTANEOUS,02/08/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215014s003lbl.pdf#page=18
emsam,selegiline,"FILM, EXTENDED RELEASE;TRANSDERMAL",07/14/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021336s014lbl.pdf#page=34
enbrel,etanercept,VIAL; SUBCUTANEOUS,09/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103795s5600lbl.pdf#page=36
enbrel,etanercept,SYRINGE,06/09/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103795s5594lbl.pdf#page=35
enhertu,fam-trastuzumab deruxtecan-nxki,INJECTABLE;INJECTION,04/05/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761139s022lbl.pdf#page=31
enjaymo,sutimlimab-jome,INJECTABLE;INJECTION,02/08/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761164s000lbl.pdf#page=13
enspryng,satralizumab-mwge,INJECTABLE;SUBCUTANEOUS,09/14/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761149s005lbl.pdf#page=16
entyvio,vedolizumab,INJECTABLE;INTRAVENOUS,04/18/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23
entyvio,vedolizumab,INJECTABLE;SUBCUTANEOUS,04/18/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23
entyvio,vedolizumab,INJECTABLE;INJECTION,04/18/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125476s038s039lbl.pdf#page=20
entyvio pen,vedolizumab,INJECTABLE;SUBCUTANEOUS,04/18/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23
envarsus xr,tacrolimus,"TABLET, EXTENDED RELEASE;ORAL",04/08/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206406s010lbl.pdf#page=29
eovist,gadoxetate disodium,SOLUTION;INTRAVENOUS,01/30/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022090s020lbledt.pdf#page=15
epidiolex,cannabidiol,SOLUTION;ORAL,03/04/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210365s020lbl.pdf#page=31
epkinly,epcoritamab-bysp,INJECTABLE;SUBCUTANEOUS,06/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761324s000lbl.pdf#page=26
epogen,epoetin alfa,VIAL; SINGLE-USE,04/30/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103234s5363s5366lbl.pdf#page=27
epzicom,abacavir sulfate; lamivudine,TABLET;ORAL,12/10/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021652s029lbl.pdf#page=28
equetro,carbamazepine,"CAPSULE, EXTENDED RELEASE;ORAL",10/14/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021710s018lbl.pdf#page=27
erelzi,etanercept-szzs,INJECTABLE; INJECTION,11/10/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761042s018lbl.pdf#page=41
erivedge,vismodegib,CAPSULE;ORAL,03/27/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203388s017lbl.pdf#page=15
esomeprazole strontium,esomeprazole strontium,"CAPSULE, DELAYED RELEASE;ORAL",03/04/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202342s007lbl.pdf#page=29
estazolam,estazolam,TABLET;ORAL,02/05/2021,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM359235.pdf
eticovo,etanercept-ykro,INJECTABLE;INJECTION,05/03/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf#page=31
evekeo odt,amphetamine sulfate,"TABLET, ORALLY DISINTEGRATING;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209905s004lbl.pdf#page=16
evenity,romosozumab-aqqg,INJECTABLE;INJECTION,12/20/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf#page=19
evista,raloxifene hydrochloride,TABLET; ORAL,09/13/2007,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf
evista,raloxifene hydrochloride,TABLET;ORAL,06/27/2018,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf
exalgo,hydromorphone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",10/07/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf#page=31
exjade,deferasirox,"TABLET, FOR SUSPENSION;ORAL",07/23/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021882s033lbl.pdf#page=28
extavia,interferon beta-1b,INJECTABLE; SUBCUTANEOUS,07/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125290s074lbl.pdf#page=16
fabhalta,iptacopan,CAPSULE;ORAL,08/07/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218276s001lbl.pdf#page=19
factive,gemifloxacin mesylate,TABLET;ORAL,07/26/2016,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021158s026lbl.pdf#page=30
farxiga,dapagliflozin,TABLET;ORAL,06/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf#page=53
farydak,panobinostat lactate,CAPSULE;ORAL,06/06/2016,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM436377.pdf
felbatol,felbamate,TABLET;ORAL,08/31/2012,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf
felbatol,felbamate,SUSPENSION;ORAL,08/31/2012,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf
feldene,piroxicam,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018147s050lbl.pdf#page=21
fensolvi kit,leuprolide acetate,POWDER;SUBCUTANEOUS,04/22/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213150s002lbl.pdf#page=15
fentanyl citrate,fentanyl citrate,TROCHE/LOZENGE;TRANSMUCOSAL,09/07/2017,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077312MedGuide.pdf
fentanyl citrate,fentanyl citrate,TROCHE/LOZENGE;TRANSMUCOSAL,12/03/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078907MedGuide.pdf
fentora,fentanyl citrate,"TABLET;BUCCAL, SUBLINGUAL",12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021947s043lbl.pdf#page=43
ferriprox,deferiprone,TABLET;ORAL,11/30/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212269s003lbl.pdf#page=17
ferriprox,deferiprone,TABLET;ORAL,11/30/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021825s010lbl.pdf#page=17
ferriprox,deferiprone,SOLUTION;ORAL,11/30/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208030s007lbl.pdf#page=13
fetzima,levomilnacipran hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",04/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204168s011lbl.pdf#page=29
filspari,sparsentan,TABLET;ORAL,02/17/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216403s000lbl.pdf#page=22
fintepla,fenfluramine hydrochloride,SOLUTION;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212102s013lbl.pdf#page=30
fioricet w/ codeine,acetaminophen; butalbital; caffeine; codeine phosphate,CAPSULE;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020232s047lbl.pdf#page=44
fiorinal w/codeine,aspirin; butalbital; caffeine; codeine phosphate,CAPSULE;ORAL,04/28/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019429s043lbl.pdf#page=39
firdapse,amifampridine phosphate,TABLET;ORAL,05/30/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208078s009lbl.pdf#page=12
flector,diclofenac epolamine,SYSTEM;TOPICAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021234s024lbl.pdf#page=24
flowtuss,guaifenesin; hydrocodone bitartrate,SOLUTION;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022424s003lbl.pdf#page=23
floxin,ofloxacin,TABLET;ORAL,02/25/2011,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019735s061MedG.pdf
fluoxetine hydrochloride,fluoxetine hydrochloride,TABLET;ORAL,08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202133s009s016lbl.pdf#page=36
focalin,dexmethylphenidate hydrochloride,TABLET;ORAL,10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021278s028s031lbl.pdf#page=17
focalin xr,dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021802s038s041lbl.pdf#page=20
foradil,formoterol fumarate,POWDER;INHALATION,03/02/2016,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088602.pdf
foradil certihaler,formoterol fumarate,POWDER;INHALATION,06/02/2010,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021592s003lbl.pdf#page=35
forfivo xl,bupropion hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",05/07/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022497s008lbl.pdf#page=33
forteo,teriparatide,SOLUTION;SUBCUTANEOUS,09/07/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021318Orig1s054lbl.pdf#page=16
fortesta,testosterone,"GEL, METERED;TRANSDERMAL",06/30/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021463s025lbl.pdf#page=21
fosamax,alendronate sodium,SOLUTION;ORAL,11/30/2015,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24"
fosamax,alendronate sodium,TABLET;ORAL,08/16/2019,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24"
fosamax plus d,alendronate sodium; cholecalciferol,TABLET;ORAL,08/16/2019,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM241521.pdf
fosamax plus d,alendronate sodium; cholecalciferol,TABLET;ORAL,08/16/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021762s022lbl.pdf#page=23
fosrenol,lanthanum carbonate,POWDER;ORAL,08/29/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204734s007,021468s025lbl.pdf#page=12"
fosrenol,lanthanum carbonate,"TABLET, CHEWABLE;ORAL",08/29/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204734s007,021468s025lbl.pdf#page=12"
fycompa,perampanel,TABLET;ORAL,05/30/2019,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf#page=24"
fycompa,perampanel,SUSPENSION;ORAL,02/23/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208277s005lbl.pdf#page=24
gabitril,tiagabine hydrochloride,TABLET;ORAL,08/09/2016,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229203.pdf
gadavist,gadobutrol,SOLUTION;INTRAVENOUS,01/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201277s020lbl.pdf#page=42
gattex kit,teduglutide recombinant,POWDER;SUBCUTANEOUS,09/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203441s022lbl.pdf#page=32
gilenya,fingolimod hydrochloride,CAPSULE;ORAL,06/05/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022527s038lbl.pdf#page=27
gimoti,metoclopramide hydrochloride,"SPRAY, METERED;NASAL",01/14/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209388s001lbl.pdf#page=17
gloperba,colchicine,SOLUTION;ORAL,08/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210942s002lbl.pdf#page=14
glyxambi,empagliflozin; linagliptin,TABLET;ORAL,10/30/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206073s036lbl.pdf#page=34
golytely,polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous,FOR SOLUTION;ORAL,05/14/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019011s033lbl.pdf#page=9
gralise,gabapentin,TABLET;ORAL,04/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022544Orig1s029lbl.pdf#page=21
h.p. acthar gel,repository corticotropin,INJECTABLE; INJECTION,10/15/2010,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231714.pdf
hadlima,adalimumab-bwwd,INJECTABLE;INJECTION,06/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761059s008lbl.pdf#page=46
halcion,triazolam,TABLET;ORAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017892s057lbl.pdf#page=20
halflytely,bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride,"FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL",06/03/2013,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM220644.pdf
hemangeol,propranolol hydrochloride,SOLUTION;ORAL,06/22/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205410s006lbl.pdf#page=11
hemlibra,emicizumab,INJECTABLE;INJECTION,01/31/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761083s015lbl.pdf#page=22
horizant,gabapentin enacarbil,"TABLET, EXTENDED RELEASE;ORAL",04/17/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022399s010lbl.pdf#page=27
hulio,adalimumab-fkjp,INJECTABLE;INJECTION,08/25/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761154s005lbl.pdf#page=57
humira,adalimumab,SYRINGE,11/03/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125057s423lbl.pdf#page=57
humira,adalimumab,VIAL,02/24/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf#page=60
hycodan,homatropine methylbromide; hydrocodone bitartrate,TABLET;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005213s046lbl.pdf#page=27
hycodan,homatropine methylbromide; hydrocodone bitartrate,SYRUP;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005213s046lbl.pdf#page=27
hycofenix,hydrocodone bitartrate;pseudoephedrine hydrochloride;guaifenesin,SOLUTION;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022279s003lbl.pdf#page=26
hydromorphone hydrochloride,hydromorphone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",03/04/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204278Orig1s000MG.pdf
hyrimoz,adalimumab-adaz,INJECTABLE;INJECTION,06/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761071s016lbl.pdf#page=60
hysingla er,hydrocodone bitartrate,"TABLET, EXTENDED RELEASE;ORAL",12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf#page=40
ibsrela,tenapanor hydrochloride,TABLET;ORAL,04/05/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211801s004lbl.pdf#page=14
iclusig,ponatinib hydrochloride,TABLET;ORAL,03/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203469s035lbl.pdf#page=34
idacio,adalimumab-aacf,INJECTABLE;SUBCUTANEOUS,06/04/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761255s004lbl.pdf#page=48
idhifa,enasidenib mesylate,TABLET;ORAL,12/21/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209606s006lbl.pdf#page=18
ilaris,canakinumab,INJECTABLE; SUBCUTANEOUS,08/25/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125319s107lbl.pdf#page=24
ilumya,tildrakizumab-asmn,INJECTABLE;INJECTION,04/03/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf#page=10
imfinzi,durvalumab,INJECTABLE;INJECTION,12/04/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761069s049lbl.pdf#page=68
imipramine hydrochloride,imipramine hydrochloride,TABLET;ORAL,06/29/2017,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3"
imjudo,tremelimumab-actl,"INJECTABLE;INTRAVENOUS, SUBCUTANEOUS",11/10/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761270s000lbl.pdf#page=32
imjudo,tremelimumab-actl,INJECTABLE;INTRAVENOUS,01/25/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761289s002lbl.pdf#page=31
incivek,telaprevir,TABLET;ORAL,03/25/2014,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM256383.pdf
indocin,indomethacin,SUPPOSITORY;RECTAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017814s045lbl.pdf
indocin,indomethacin,SUSPENSION;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018332s043lbl.pdf
indocin,indomethacin,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016059s102lbl.pdf#page=25
indocin sr,indomethacin,"CAPSULE, EXTENDED RELEASE;ORAL",11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018185s059lbl.pdf#page=26
indomethacin,indomethacin,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018829s025lbl.pdf#page=18
indomethacin,indomethacin,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018851s028lbl.pdf#page=23
indomethacin,indomethacin,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018858s049lbl.pdf
inflectra,infliximab-dyyb,INJECTABLE;INJECTION,06/17/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125544s018lbl.pdf#page=61
inpefa,sotagliflozin,TABLET; ORAL,05/26/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216203s000lbl.pdf#page=24
inrebic,fedratinib hydrochloride,CAPSULE;ORAL,05/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212327s005lbl.pdf#page=21
intermezzo,zolpidem tartrate,TABLET;SUBLINGUAL,08/18/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022328s008lbl.pdf#page=20
intron a,interferon alfa-2b,VIAL,11/26/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103132s5196lbl.pdf#page=40
invirase,saquinavir mesylate,CAPSULE;ORAL,03/28/2019,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf#page=24"
invirase,saquinavir mesylate,TABLET;ORAL,09/18/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021785s025lbl.pdf#page=25
invokamet,canagliflozin; metformin hydrochloride,TABLET;ORAL,08/23/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204353s045,205879s022lbl.pdf#page=58"
invokamet xr,canagliflozin; metformin hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",08/23/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204353s045,205879s022lbl.pdf#page=58"
invokana,canagliflozin,TABLET;ORAL,08/23/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204042s041s042lbl.pdf#page=48
ixifi,infliximab-qbtx,INJECTABLE;INJECTION,12/26/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761072s009lbl.pdf#page=46
jadenu,deferasirox,TABLET;ORAL,07/23/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206910s015lbl.pdf#page=31
jadenu sprinkle,deferasirox,GRANULE;ORAL,07/23/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207968s009lbl.pdf#page=31
janumet,metformin hydrochloride; sitagliptin phosphate,TABLET;ORAL,06/21/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022044s052lbl.pdf#page=33
janumet xr,metformin hydrochloride; sitagliptin phosphate,"TABLET, EXTENDED RELEASE;ORAL",06/21/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202270s026lbl.pdf#page=34
januvia,sitagliptin phosphate,TABLET;ORAL,06/21/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf#page=27
jardiance,empagliflozin,TABLET;ORAL,09/21/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf#page=47
jemperli,dostarlimab-gxly,INJECTABLE;INJECTION,08/01/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761174s009lbl.pdf#page=37
jemperli,dostarlimab-gxly,INJECTABLE;INJECTION,08/17/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761223s000lbl.pdf#page=25
jentadueto,linagliptin; metformin hydrochloride,TABLET;ORAL,06/20/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201281s035lbl.pdf#page=21
jentadueto xr,linagliptin; metformin hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",06/20/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208026s024lbl.pdf#page=22
jesduvroq,daprodustat,TABLET;ORAL,02/01/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216951s000lbl.pdf#page=23
jeuveau,prabotulinumtoxina-xvfs,INJECTABLE;INJECTION,07/12/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s000lbl.pdf#page=9
jornay pm,methylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209311s010lbl.pdf#page=20
juvisync,simvastatin; sitagliptin phosphate,TABLET;ORAL,02/24/2014,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM275945.pdf
juxtapid,lomitapide mesylate,CAPSULE;ORAL,05/27/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203858s017lbl.pdf#page=32
jynarque,tolvaptan,TABLET;ORAL,11/25/2020,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204441lbl.pdf#page=18
kadian,morphine sulfate,"CAPSULE, EXTENDED RELEASE;ORAL",03/04/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020616s065lbl.pdf#page=36
kalbitor,ecallantide,INJECTABLE; INJECTION,12/28/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125277s081lbl.pdf#page=13
kaletra,lopinavir; ritonavir,TABLET;ORAL,10/21/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf#page=53"
kaletra,lopinavir; ritonavir,CAPSULE;ORAL,10/21/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021226s049lbl.pdf#page=53
kaletra,lopinavir; ritonavir,SOLUTION;ORAL,10/21/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf#page=53"
kazano,alogliptin benzoate; metformin hydrochloride,TABLET;ORAL,07/27/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203414s016lbl.pdf#page=32
keppra,levetiracetam,TABLET;ORAL,03/12/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021035s113,021505s052lbl.pdf#page=32"
keppra,levetiracetam,SOLUTION;ORAL,03/12/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021035s113,021505s052lbl.pdf#page=32"
keppra xr,levetiracetam,"TABLET, EXTENDED RELEASE;ORAL",03/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022285s034lbl.pdf#page=26
kesimpta,ofatumumab,SOLUTION;SUBCUTANEOUS,04/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125326s075lbl.pdf#page=13
ketek,telithromycin,TABLET;ORAL,11/04/2015,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021144s019lbl.pdf#page=29
kevzara,sarilumab,INJECTABLE;INJECTION,06/10/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761037s013lbl.pdf#page=31
keytruda,pembrolizumab,SOLUTION;INTRAVENOUS,09/17/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125514s161lbl.pdf#page=165
khedezla,desvenlafaxine,"TABLET, EXTENDED RELEASE;ORAL",09/20/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204683s007lbl.pdf#page=24
klonopin,clonazepam,TABLET;ORAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017533s062lbl.pdf#page=24
kombiglyze xr,metformin hydrochloride; saxagliptin hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",07/01/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200678s024lbl.pdf#page=47
konvomep,omeprazole; sodium bicarbonate,SUSPENSION;ORAL,08/30/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213593s000lbl.pdf#page=28
korlym,mifepristone,TABLET;ORAL,11/05/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf#page=20
krystexxa,pegloticase,INJECTABLE; INJECTION,07/07/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125293s104lbl.pdf#page=18
kynamro,mipomersen sodium,SOLUTION;SUBCUTANEOUS,03/18/2019,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337730.pdf
lacosamide,lacosamide,SOLUTION;ORAL,10/27/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LacosamideTabletsCVMedGuide.pdf
lacosamide,lacosamide,TABLET;ORAL,10/27/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE TABLETSMedGuide.pdf
lacosamide,lacosamide,TABLET;ORAL,08/10/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE ORAL SOLUTIONMed Guide.pdf
lamictal,lamotrigine,TABLET;ORAL,03/31/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65"
lamictal cd,lamotrigine,"TABLET, FOR SUSPENSION;ORAL",03/31/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65"
lamictal odt,lamotrigine,"TABLET, ORALLY DISINTEGRATING;ORAL",03/31/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65"
lamictal xr,lamotrigine,"TABLET, EXTENDED RELEASE;ORAL",03/31/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022115s029lbl.pdf#page=51
lamictal xr,lamotrigine,"TABLET, EXTENDED RELEASE; ORAL",01/29/2010,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022509lbl.pdf#page=39
lamisil,terbinafine hydrochloride,TABLET;ORAL,03/29/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf#page=11
lamisil,terbinafine hydrochloride,GRANULE;ORAL,03/29/2019,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020539s029,022071s013lbl.pdf#page=10"
"lamivudine, nevirapine and zidovudine",lamivudine; nevirapine; zidovudine,TABLET;ORAL,08/13/2018,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205626s000lbl.pdf#page=50
lariam,mefloquine hydrochloride,TABLET;ORAL,04/29/2011,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019591s026s028lbl.pdf#page=13
latuda,lurasidone hydrochloride,TABLET;ORAL,12/04/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200603s035lbl.pdf#page=62
lazanda,fentanyl citrate,"SPRAY, METERED;NASAL",12/03/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022569s030lbl.pdf#page=35
lemtrada,alemtuzumab,INJECTABLE;INJECTION,05/20/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103948s5185lbl.pdf#page=30
leqembi,ecanemab-irmb,INJECTABLE;INTRAVENOUS,07/06/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s001lbl.pdf#page=21
letairis,ambrisentan,TABLET;ORAL,06/08/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf#page=26
levaquin,levofloxacin,SOLUTION;ORAL,02/08/2017,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59"
levaquin,levofloxacin,TABLET;ORAL,02/08/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf#page=54
levaquin,levofloxacin,INJECTABLE;INJECTION,02/08/2017,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59"
levaquin,levofloxacin,INJECTABLE;INJECTION,02/08/2017,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59"
lexapro,escitalopram oxalate,TABLET;ORAL,04/19/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s057,021365s040lbl.pdf#page=30"
lexapro,escitalopram oxalate,SOLUTION;ORAL,04/19/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s057,021365s040lbl.pdf#page=30"
librax,chlordiazepoxide hydrochloride; clidinium bromide,CAPSULE;ORAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012750s068lbl.pdf#page=13
librium,chlordiazepoxide hydrochloride,CAPSULE;ORAL,12/16/2016,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012249s049lbl.pdf#page=8
libtayo,cemiplimab-rwlc,INJECTABLE;INTRAVENOUS,04/05/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761097s016lbl.pdf#page=36
licart,diclofenac epolamine,SYSTEM;TOPICAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206976s016lbl.pdf#page=21
limbitrol,amitriptyline hydrochloride; chlordiazepoxide,TABLET;ORAL,02/05/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016949s041lbl.pdf#page=14
limbitrol ds,amitriptyline hydrochloride; chlordiazepoxide,TABLET;ORAL,02/05/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016949s041lbl.pdf#page=14
lindane,lindane,SHAMPOO;TOPICAL,04/05/2004,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneLotionMedGuide.pdf
lindane,lindane,LOTION;TOPICAL,09/04/2001,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneShampooMedGuide.pdf
linzess,linaclotide,CAPSULE;ORAL,06/12/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202811s021lbl.pdf#page=23
lithium carbonate,lithium carbonate,CAPSULE;ORAL,10/13/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19"
lithium carbonate,lithium carbonate,TABLET;ORAL,10/13/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19"
lithium citrate,lithium citrate,SYRUP;ORAL,10/13/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19"
loqtorzi,toripalimab-tpzi,INJECTABLE;INTRAVENOUS,04/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761240s000lbl.pdf#page=24
loreev xr,lorazepam,"CAPSULE, EXTENDED RELEASE;ORAL",01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214826s003lbl.pdf#page=16
lotronex,alosetron hydrochloride,TABLET;ORAL,04/03/2019,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088624.pdf
lumoxiti,moxetumomab pasudotox-tdfk,INJECTABLE;INJECTION,08/20/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761104s003lbl.pdf#page=18
lunesta,eszopiclone,TABLET;ORAL,08/18/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476Orig1s038rplLBL.pdf#page=26
lunsumio,mosunetuzumab-axgb,INJECTABLE;INTRAVENOUS,11/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761263s005lbl.pdf#page=19
lupaneta pack,"leuprolide acetate for depot suspension, norethindrone acetate usp",INJECTABLE;INTRAMUSCULAR; TABLET;ORAL,08/09/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203696s005s006lbl.pdf#page=30
lupkynis,voclosporin,CAPSULE;ORAL,04/29/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213716s000lbl.pdf#page=23
lupron,leuprolide acetate,INJECTABLE;INJECTION,12/10/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019010s038lbl.pdf#page=27
lupron depot-ped kit,leuprolide acetate,POWDER;INTRAMUSCULAR,04/14/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020263s053lbl.pdf#page=26
luvox,fluvoxamine maleate,TABLET;ORAL,08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021519s026lbl.pdf#page=32
luvox cr,fluvoxamine maleate,"CAPSULE, EXTENDED RELEASE;ORAL",01/04/2017,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022033s011lbl.pdf#page=26
lybalvi,olanzapine; samidorphan l-malate,TABLET;ORAL,01/30/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213378s000lbl.pdf#page=40
lynparza,olaparib,CAPSULE;ORAL,09/27/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206162s011lbl.pdf#page=16
lynparza,olaparib,TABLET;ORAL,11/06/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208558s028lbl.pdf#page=58
lyrica,pregabalin,CAPSULE;ORAL,12/15/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021446s041,022488s018lbl.pdf#page=57"
lyrica,pregabalin,SOLUTION;ORAL,12/13/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021446s041,022488s018lbl.pdf#page=57"
lyrica cr,pregabalin,"TABLET, EXTENDED RELEASE;ORAL",12/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209501s005lbl.pdf#page=31
magnevist,gadopentetate dimeglumine,INJECTABLE;INJECTION,07/25/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019596s064s065lbl.pdf#page=12
magnevist,gadopentetate dimeglumine,INJECTABLE;INJECTION,07/25/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021037s037s038lbl.pdf#page=13
marplan,isocarboxazid,TABLET;ORAL,11/08/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011961s045lbl.pdf#page=16
mavenclad,cladribine,TABLET;ORAL,09/19/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022561s006lbl.pdf#page=29
mayzent,siponimod fumaric acid,TABLET;ORAL,06/05/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209884s016s018lbl.pdf#page=23
mektov,binimetinib,TABLET;ORAL,09/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210498s010lbl.pdf#page=21
meridia,sibutramine hydrochloride,CAPSULE;ORAL,08/04/2010,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020632s034s035MedGuide.pdf
metadate cd,methylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021259s034lbl.pdf#page=16
methylin,methylphenidate hydrochloride,SOLUTION;ORAL,10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021419s023lbl.pdf#page=17
methylin,methylphenidate hydrochloride,"TABLET, CHEWABLE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021475s012lbl.pdf#page=13
metoclopramide hydrochloride,metoclopramide hydrochloride,SOLUTION;ORAL,04/08/2014,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM244086.pdf
metozolv odt,metoclopramide hydrochloride,"TABLET, ORALLY DISINTEGRATING;ORAL",02/28/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022246s009lbl.pdf#page=18
mifeprex,mifepristone,TABLET; ORAL,03/23/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020687Orig1s026lbl.pdf#page=16
mircera,methoxy polyethylene glycol-epoetin beta,SOLUTION; INJECTION,06/04/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125164s087lblcorretion.pdf#page=23
mircera,methoxy polyethylene glycol-epoetin beta,INJECTABLE; SUBCUTANEOUS,04/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/126164s087lbl.pdf#page=27
mitigare,colchicine,CAPSULE;ORAL,09/26/2014,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204820s000lbl.pdf#page=11
mitigare,colchicine,CAPSULE;ORAL,09/26/2014,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM417495.pdf
mobic,meloxicam,TABLET;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020938s030lbl.pdf#page=16
mobic,meloxicam,SUSPENSION;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021530s020lbl.pdf#page=16
morphabond er,morphine sulfate,"TABLET, EXTENDED RELEASE;ORAL",10/07/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206544s012lbl.pdf#page=38
morphine sulfate,morphine sulfate,SOLUTION;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201517s018lbl.pdf#page=30
morphine sulfate,morphine sulfate,SOLUTION;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022195s021lbl.pdf#page=23
morphine sulfate,morphine sulfate,TABLET;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022207s011lbl.pdf#page=29
motpoly xr,lacosamide,"CAPSULE, EXTENDED RELEASE;ORAL",06/07/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216185s000lbl.pdf#page=22
motrin,ibuprofen,TABLET;ORAL,09/10/2007,https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017463s104lbl.pdf#page=13
mounjaro,tirzepatide,INJECTABLE; SUBCUTANEOUS,07/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215866s002s006lbl.pdf#page=20
movantik,naloxegol oxalate,TABLET;ORAL,04/13/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204760s009lbl.pdf#page=16
moviprep,ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate,FOR SOLUTION;ORAL,05/14/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021881s023lbl.pdf#page=13
moxifloxacin hydrochloride,moxifloxacin hydrochloride,SOLUTION;INTRAVENOUS,07/26/2016,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205572s007lbl.pdf#page=49
ms contin,morphine sulfate,"TABLET, EXTENDED RELEASE;ORAL",12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019516s058lbl.pdf#page=32
multaq,dronedarone hydrochloride,TABLET;ORAL,10/23/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022425s028s030lbl.pdf#page=24
multihance,gadobenate dimeglumine,INJECTABLE;INTRAVENOUS,08/14/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021357s026,021358s024lbl.pdf#page=36"
multihance multipack,gadobenate dimeglumine,INJECTABLE;INTRAVENOUS,08/14/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021357s026,021358s024lbl.pdf#page=36"
myalept,metreleptin,INJECTABLE;INJECTION,02/28/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125390s024lbl.pdf#page=16
mydayis,amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022063s005lbl.pdf#page=25
myfortic,mycophenolic sodium,"TABLET, DELAYED RELEASE;ORAL",03/15/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050791s035lbl.pdf#page=23
myobloc,botulinum toxin type b,VIAL,03/10/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf#page=17
mysoline,primidone,TABLET;ORAL,06/10/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009170Orig1s040lbl.pdf#page=7
nalfon,fenoprofen calcium,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017604s054lbl.pdf#page=16
naprelan,naproxen sodium,"TABLET, EXTENDED RELEASE;ORAL",11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020353s041lbl.pdf#page=21
naprosyn,naproxen,SUSPENSION;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018965s028lbl.pdf#page=22
naprosyn,naproxen,TABLET;ORAL,11/21/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf"
nardil,phenelzine sulfate,TABLET;ORAL,08/02/2007,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088660.pdf
natpara,parathyroid hormone,INJECTABLE;INJECTION,07/01/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s016lbl.pdf#page=18
nayzilam,midazolam,SPRAY;NASAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211321s008lbl.pdf#page=26
nesina,alogliptin benzoate,TABLET;ORAL,07/27/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022271s015lbl.pdf#page=28
neurontin,gabapentin,SOLUTION;ORAL,12/16/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28"
neurontin,gabapentin,TABLET;ORAL,12/16/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28"
neurontin,gabapentin,CAPSULE;ORAL,12/16/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28"
nexium,esomeprazole magnesium,"FOR SUSPENSION, DELAYED RELEASE;ORAL",07/18/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40"
nexium,esomeprazole magnesium,"CAPSULE, DELAYED REL PELLETS;ORAL",07/18/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40"
nexium,esomeprazole magnesium,"FOR SUSPENSION, DELAYED RELEASE;ORAL",07/18/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40"
nizoral,ketoconazole,TABLET;ORAL,07/30/2013,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018533s040lbl.pdf#page=19
nocdurna,desmopressin acetate,TABLET;SUBLINGUAL,06/21/2018,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf#page=14
noctiva,desmopressin acetate,"SPRAY, METERED;NASAL",03/03/2017,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201656lbl.pdf#page=13
nolvadex,tamoxifen citrate,TABLET;ORAL,03/13/2009,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088661.pdf
norco,acetaminophen; hydrocodone bitartrate,TABLET;ORAL,03/04/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/040099s023lbl.pdf#page=23
noroxin,norfloxacin,TABLET;ORAL,07/26/2016,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM246795.pdf
norpramin,desipramine hydrochloride,TABLET;ORAL,11/09/2018,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/014399s066s067mg.pdf
novantrone,mitoxantrone hydrochloride,INJECTABLE;INJECTION,03/23/2012,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019297s035mg.pdf
nplate,romiplostim,INJECTABLE; SUBCUTANEOUS,02/10/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125268s167lbl.pdf#page=18
nucynta,tapentadol hydrochloride,TABLET;ORAL,06/14/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022304s026lbl.pdf#page=40
nucynta,tapentadol hydrochloride,SOLUTION;ORAL,06/14/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203794s011lbl.pdf#page=37
nucynta er,tapentadol hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",06/14/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200533s027lbl.pdf#page=40
nulojix,belatacept,INJECTABLE; INJECTION,07/28/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125288s075lbl.pdf#page=49
nulytely,polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride,FOR SOLUTION;ORAL,05/14/2021,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf
nulytely-flavored,polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride,FOR SOLUTION;ORAL,05/14/2021,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf
nuvigil,armodafinil,TABLET;ORAL,02/07/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021875s023lbl.pdf#page=24
obredon,guaifenesin; hydrocodone bitartrate,SOLUTION;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205474s008lbl.pdf#page=23
ocaliva,obeticholic acid,TABLET;ORAL,05/26/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207999s007lbl.pdf#page=22
ocrevus,ocrelizumab,INJECTABLE;INJECTION,06/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761053s031lbl.pdf#page=20
ocrevus zunovo,ocrelizumab and hyaluronidazse-ocsq,INJECTABLE;SUBCUTANEOUS,09/13/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761371s000lbl.pdf#page=21
odomzo,sonidegib phosphate,CAPSULE;ORAL,08/22/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205266s009lbl.pdf#page=14
oleptro,trazodone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",07/17/2014,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM202202.pdf
olumiant,baricitinib,TABLET;ORAL,05/10/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207924s006lbl.pdf#page=26
omniscan,gadodiamide,INJECTABLE;INJECTION,01/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022066s008lbl.pdf#page=1
omniscan,gadodiamide,INJECTABLE;INJECTION,01/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020123s046lbl.pdf#page=1
omontys,peginesatide acetate,"SOLUTION;INTRAVENOUS, SUBCUTANEOUS",12/04/2012,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202799s001lbl.pdf#page=15
omvoh,mirikizumab-mrkz,"INJECTABLE;INTRAVENOUS, SUBCUTANEOUS",04/29/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761279s000lbl.pdf#page=15
onfi,clobazam,TABLET;ORAL,03/12/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf#page=29"
onfi,clobazam,SUSPENSION;ORAL,03/12/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf#page=29"
onglyza,saxagliptin hydrochloride,TABLET;ORAL,07/01/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022350s023lbl.pdf#page=31
onsolis,fentanyl citrate,FILM;BUCCAL,12/03/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022266s025lbl.pdf#page=32
opana,oxymorphone hydrochloride,TABLET;ORAL,10/25/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021611s016lbl.pdf#page=27
opana er,oxymorphone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021610s031lbl.pdf#page=32
opana er,oxymorphone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",10/07/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201655s026lbl.pdf#page=26
opdivo,nivolumab,INJECTABLE;INJECTION,10/03/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125554s127lbl.pdf#page=166
opsumit,macitentan,TABLET;ORAL,05/26/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204410s024lbl.pdf#page=20
optimark,gadoversetamide,INJECTABLE;INJECTION,11/02/2018,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=14"
optimark,gadoversetamide,INJECTABLE;INJECTION,11/02/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020975s028lbl.pdf#page=13
optimark in plastic container,gadoversetamide,INJECTABLE;INJECTION,11/02/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020976s029lbl.pdf#page=13
opzelura,ruxolitinib phosphate,CREAM;TOPICAL,03/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215309s004lbl.pdf#page=19
oriahnn (copackaged),"elagolix sodium,estradiol,norethindrone acetate; elagolix sodium",CAPSULE;ORAL,05/29/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213388s003lbl.pdf#page=29
orilissa,elagolix sodium,TABLET;ORAL,06/05/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210450s009lbl.pdf#page=27
oseni,alogliptin benzoate; pioglitazone hydrochloride,TABLET;ORAL,06/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022426s012lbl.pdf#page=43
osmoprep,"sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate",TABLET;ORAL,11/29/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021892s014lbl.pdf#page=13
otulfi,ustekinumab-aauz,INJECTABLE;INTRAVENOUS,09/27/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761379s000lbl.pdf#page=36
oxaydo,oxycodone hydrochloride,TABLET;ORAL,04/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202080s013lbl.pdf#page=30
oxtellar xr,oxcarbazepine,"TABLET, EXTENDED RELEASE;ORAL",08/14/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf#page=24
oxycodone hydrochloride,oxycodone hydrochloride,SOLUTION;ORAL,04/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200535s022lbl.pdf#page=35
oxycodone hydrochloride,oxycodone hydrochloride,SOLUTION;ORAL,04/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201194s017lbl.pdf#page=34
oxycodone hydrochloride capsules,oxycodone hydrochloride,CAPSULE;ORAL,04/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200534s013lbl.pdf#page=32
oxycontin,oxycodone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022272s048lbl.pdf#page=49
oxymorphone hydrochloride,oxymorphone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",03/04/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/079046s000mg.pdf
ozempic,semaglutide,SOLUTION;SUBCUTANEOUS,10/06/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s012lbl.pdf#page=27
pacerone,amiodarone hydrochloride,TABLET;ORAL,11/01/2019,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088668.pdf
palladone,hydromorphone hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",04/16/2014,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088670.pdf
palynziq,pegvaliase-pqpz,INJECTABLE;INJECTION,11/20/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761079s000lbl.pdf#page=23
pamelor,nortriptyline hydrochloride,SOLUTION;ORAL,07/28/2014,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088671.pdf
pamelor,nortriptyline hydrochloride,CAPSULE;ORAL,04/09/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf#page=15
pancreaze,pancrelipase (amylase;lipase;protease),"CAPSULE, DELAYED RELEASE;ORAL",02/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022523s013lbl.pdf#page=16
parnate,tranylcypromine sulfate,TABLET;ORAL,01/04/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012342s064lbl.pdf#page=18
paxil,paroxetine hydrochloride,SUSPENSION;ORAL,11/26/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf#page=39"
paxil,paroxetine hydrochloride,TABLET;ORAL,11/26/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf#page=39"
paxil cr,paroxetine hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",02/23/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020936s057s064lbl.pdf#page=30
peganone,ethotoin,TABLET;ORAL,02/27/2017,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010841s022MedGuide.pdf
pegasys,peginterferon alfa-2a,VIAL; SUBCUTANEOUS,12/11/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103964s5276lbl.pdf#page=37
pegasys,peginterferon alfa-2a,SYRINGE,12/11/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103964s5276lbl.pdf#page=37
pegintron,peginterferon alfa-2b,SYRINGE,12/21/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf#page=29
pennsaid,diclofenac sodium,SOLUTION;TOPICAL,05/09/2016,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191085.pdf
pennsaid,diclofenac sodium,SOLUTION;TOPICAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204623s013lbl.pdf#page=20
percocet,acetaminophen; oxycodone hydrochloride,TABLET;ORAL,03/04/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf
percodan,aspirin; oxycodone hydrochloride; oxycodone terephthalate,TABLET;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/007337s057lbl.pdf
percodan,aspirin; oxycodone hydrochloride,TABLET;ORAL,04/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/007337s053lbl.pdf#page=30
perforomist,formoterol fumarate,SOLUTION;INHALATION,05/29/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022007s014lbl.pdf#page=19
pertzye,pancrelipase (amylase;lipase;protease),"CAPSULE, DELAYED RELEASE;ORAL",02/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022175s008lbl.pdf#page=13
pexeva,paroxetine mesylate,TABLET;ORAL,08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021299s035s038lbl.pdf#page=18
phenergan vc w/ codeine,codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride,SYRUP;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/008306s035lbl.pdf#page=66
phenergan w/ codeine,codeine phosphate; promethazine hydrochloride,SYRUP;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/008306s035lbl.pdf#page=66
plavix,clopidogrel bisulfate,TABLET;ORAL,03/01/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020839s074lbl.pdf#page=24
plegridy,peginterferon beta-1a,INJECTABLE;INJECTION,07/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125499s028lbl.pdf#page=20
plenvu,ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate,FOR SOLUTION;ORAL,09/08/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209381s013lbl.pdf#page=18
pomalyst,pomalidomide,CAPSULE;ORAL,03/24/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204026s031lbl.pdf#page=33
ponstel,mefenamic acid,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/015034s046lbl.pdf
ponvory,ponesimod,TABLET;ORAL,06/05/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213498s004lbl.pdf#page=30
potiga,ezogabine,TABLET;ORAL,05/20/2016,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM259619.pdf
pradaxa,dabigatran etexilate mesylate,CAPSULE;ORAL,11/17/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022512s047lbl.pdf#page=27
pradaxa,dabigatran etexilate mesylate,PELLETS;ORAL,11/14/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214358s007lbl.pdf#page=14
prepopik,citric acid; magnesium oxide; sodium picosulfate,FOR SOLUTION;ORAL,08/29/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202535s006lbl.pdf#page=15
pretomanid,pretomanid,TABLET;ORAL,11/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212862s008lbl.pdf#page=27
prevacid,lansoprazole,"CAPSULE, DELAYED REL PELLETS;ORAL",08/08/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf#page=45"
prevacid,lansoprazole,"TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL",08/08/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf#page=45"
prevacid naprapac 250 (copackaged),lansoprazole; naproxen,"CAPSULE, DELAYED REL PELLETS, TABLET;ORAL",07/31/2009,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf
prevacid naprapac 375 (copackaged),lansoprazole; naproxen,"CAPSULE, DELAYED REL PELLETS, TABLET;ORAL",07/31/2009,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf
prevacid naprapac 500 (copackaged),lansoprazole; naproxen,"CAPSULE, DELAYED REL PELLETS, TABLET;ORAL",07/31/2009,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf
priftin,rifapentine,TABLET;ORAL,07/01/2015,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021024s017s018lbl.pdf#page=28
prilosec,omeprazole magnesium,"FOR SUSPENSION, DELAYED RELEASE;ORAL",07/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022056s026lbl.pdf#page=34
prilosec,omeprazole,"CAPSULE, DELAYED REL PELLETS;ORAL",12/19/2016,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s103,022056s020lbl.pdf#page=34"
pristiq,desvenlafaxine succinate,"TABLET, EXTENDED RELEASE;ORAL",11/10/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s047lbl.pdf#page=36
probuphine,buprenorphine hydrochloride,IMPLANT;IMPLANTATION,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204442s014lbl.pdf#page=47
procrit,epoetin alfa,VIAL; SINGLE-USE,04/30/2024,https://www.fda.gov/media/73511/download
prohance,gadoteridol,INJECTABLE;INJECTION,08/14/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020131s042,021489s023lbl.pdf#page=32"
prohance multipack,gadoteridol,INJECTABLE;INJECTION,08/14/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020131s042,021489s023lbl.pdf#page=32"
prolia,denosumab,INJECTABLE; SUBCUTANEOUS,01/03/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125320s211lbl.pdf#page=31
promacta,eltrombopag olamine,TABLET;ORAL,03/09/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf#page=35"
promacta kit,eltrombopag olamine,FOR SUSPENSION;ORAL,03/09/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf#page=35"
propulsid,cisapride monohydrate,TABLET;ORAL,03/06/2000,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Propulsid.pdf
propylthiouracil,propylthiouracil,TABLET;ORAL,09/19/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006188s026lbl.pdf#page=7
proquin xr,ciprofloxacin hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",08/15/2011,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Proquin XR.pdf
protonix,pantoprazole sodium,"FOR SUSPENSION, DELAYED RELEASE;ORAL",07/18/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020987s060,022020s023lbl.pdf#page=31"
protonix,pantoprazole sodium,"TABLET, DELAYED RELEASE;ORAL",07/18/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020987s060,022020s023lbl.pdf#page=31"
protopic,tacrolimus,OINTMENT;TOPICAL,02/25/2019,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088996.pdf
provigil,modafinil,TABLET;ORAL,01/15/2015,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036MedGuide.pdf
prozac,fluoxetine hydrochloride,CAPSULE;ORAL,08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018936 s112lbl.pdf#page=26
prozac weekly,fluoxetine hydrochloride,"CAPSULE, DELAYED REL PELLETS;ORAL",03/24/2017,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf#page=28"
qdolo,tramadol hydrochloride,SOLUTION;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214044s002lbl.pdf#page=28
qelbree,viloxazine hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",04/29/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211964s003lbl.pdf#page=21
qmiiz odt,meloxicam,"TABLET, ORALLY DISINTEGRATING;ORAL",04/28/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211210s002lbl.pdf#page=37
qsymia,phentermine hydrochloride; topiramate,"CAPSULE, EXTENDED RELEASE;ORAL",09/13/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022580s025lbl.pdf#page=43
qtern,dapagliflozin; saxagliptin hydrochloride,TABLET;ORAL,09/12/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209091s008lbl.pdf#page=37
qternmet xr,dapagliflozin; metformin hydrochloride; saxagliptin hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",01/24/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210874s003lbl.pdf#page=47
qualaquin,quinine sulfate,CAPSULE;ORAL,06/19/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021799s029lbl.pdf#page=26
qudexy xr,topiramate,"CAPSULE, EXTENDED RELEASE;ORAL",03/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205122s014lbl.pdf#page=54
quillichew er,methylphenidate hydrochloride,"TABLET, EXTENDED RELEASE, CHEWABLE;ORAL",06/25/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207960s012lbl.pdf#page=21
quillivant xr,methylphenidate hydrochloride,"FOR SUSPENSION, EXTENDED RELEASE;ORAL",06/25/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202100s018lbl.pdf#page=21
quviviq,daridorexant,TABLET; ORAL,09/30/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214985s010s012lbl.pdf#page=24
raldesy,"trazodone hydrochloride, usp",SOLUTION;ORAL,11/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218637s000lbl.pdf#page=12
rapamune,sirolimus,SOLUTION;ORAL,01/02/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021083s067,021110s085lbl.pdf#page=43"
rapamune,sirolimus,TABLET;ORAL,08/09/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021110s086lbl.pdf#page=43
ravicti,glycerol phenylbutyrate,LIQUID;ORAL,09/03/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284s012lbl.pdf#page=27
rebetol,ribavirin,SOLUTION;ORAL,03/16/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020903s057,021546s013lbl.pdf#page=26"
rebetol,ribavirin,CAPSULE;ORAL,03/16/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020903s057,021546s013lbl.pdf#page=26"
rebif,interferon beta-1a,SYRINGE,07/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103780s5214lbl.pdf#page=16
reclast,zoledronic acid,INJECTABLE;INTRAVENOUS,04/29/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021817s028lbl.pdf#page=25
recorlev,levoketoconazole,TABLET;ORAL,08/16/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214133s003lbl.pdf#page=3
reglan,metoclopramide hydrochloride,TABLET;ORAL,08/29/2017,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM235574.pdf
reglan,metoclopramide hydrochloride,INJECTABLE;INJECTION,11/18/2010,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017862s063MedGuide.pdf
reglan odt,metoclopramide hydrochloride,"TABLET, ORALLY DISINTEGRATING;ORAL",11/30/2011,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021793s011mg.pdf
regranex,becaplermin,GEL; TOPICAL,08/26/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103691s5138lbl.pdf#page=8
relexxii,methylphenidate hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216117s001lbl.pdf#page=25
relistor,methylnaltrexone bromide,SOLUTION;SUBCUTANEOUS,03/14/2018,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf#page=24"
relistor,methylnaltrexone bromide,TABLET;ORAL,03/14/2018,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf#page=24"
remeron,mirtazapine,TABLET;ORAL,11/18/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf#page=23"
remeron soltab,mirtazapine,"TABLET, ORALLY DISINTEGRATING;ORAL",11/18/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf#page=23"
remicade,infliximab,VIAL,10/05/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103772s5401lbl.pdf#page=50
renflexis,infliximab-abda,INJECTABLE;INJECTION,12/26/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761054s021lbl.pdf#page=55
restoril,temazepam,CAPSULE;ORAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018163s071lbl.pdf#page=17
retacrit,epoetin alfa-epbx,INJECTABLE;INJECTION,06/04/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125545s005lbl.pdf#page=31
revlimid,lenalidomide,CAPSULE;ORAL,03/24/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021880s067lbl.pdf#page=48
rexulti,brexpiprazole,TABLET;ORAL,05/07/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205422s009lbl.pdf#page=36
reyvow,lasmiditan succinate,TABLET;ORAL,09/15/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211280s008lbl.pdf#page=15
rezira,hydrocodone bitartrate; pseudoephedrine hydrochloride,SOLUTION;ORAL,06/28/2018,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022442s010lbl.pdf#page=26
riabni,rituximab-arrx,INJECTABLE;INJECTION,06/03/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761140s001lbl.pdf#page=41
rinvoq,upadacitinib,"TABLET, EXTENDED RELEASE;ORAL",04/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211675s019lbl.pdf#page=72
ritalin,methylphenidate hydrochloride,TABLET;ORAL,10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/010187s092s096lbl.pdf#page18
ritalin la,methylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021284s042s046lbl.pdf#page18
ritalin-sr,methylphenidate hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",11/19/2019,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf#page=13"
rituxan,rituximab,SOLUTION;INTRAVENOUS,12/17/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103705s5465lbl.pdf#page=56
rituxan hycela,rituximab; hyaluronidase (human recombinant),SOLUTION;SUBCUTANEOUS,06/10/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761064s013lbl.pdf#page=28
roxicodone,oxycodone hydrochloride,TABLET;ORAL,04/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021011s013lbl.pdf#page=30
roxybond,oxycodone hydrochloride,TABLET;ORAL,04/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209777s008lbl.pdf#page=38
rozerem,ramelteon,TABLET;ORAL,11/03/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021782s022lbl.pdf#page=17
ruxience,rituximab-pvvr,INJECTABLE;INJECTION,10/16/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761103s011lbl.pdf#page=42
ruzurgi,amifampridine,TABLET;ORAL,08/21/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209321s000lbl.pdf#page=15
rybelsus,semaglutide,TABLET;ORAL,01/24/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213051s012lbl.pdf#page=24
rybelsus,semaglutide,TABLET;ORAL,01/16/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213182s000,213051s001lbl.pdf#page=23"
sabril,vigabatrin,FOR SOLUTION;ORAL,10/20/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf#page=26"
sabril,vigabatrin,TABLET;ORAL,10/20/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf#page=26"
samsca,tolvaptan,TABLET;ORAL,04/22/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022275s017lbl.pdf#page=19
sarafem,fluoxetine hydrochloride,TABLET;ORAL,09/20/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021860s015lbl.pdf#page=32
savaysa,edoxaban tosylate,TABLET;ORAL,10/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206316s019lbl.pdf#page=35
savella,milnacipran hydrochloride,TABLET;ORAL,05/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022256s028lbl.pdf#page=31
saxenda,liraglutide recombinant,SOLUTION;SUBCUTANEOUS,04/20/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206321s016lbl.pdf#page=30
seglentis,celecoxib; tramadol hydrochloride,TABLET;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213426s003lbl.pdf#page=57
segluromet,ertugliflozin; metformin hydrochloride,TABLET;ORAL,09/12/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209806s010lbl.pdf#page=33
selzentry,maraviroc,SOLUTION;ORAL,10/30/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128s019,208984s002lbl.pdf#page=43"
selzentry,maraviroc,TABLET;ORAL,10/30/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128s019,208984s002lbl.pdf#page=43"
serevent,salmeterol xinafoate,POWDER;INHALATION,07/22/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020692s047lbl.pdf#page=35
seroquel,quetiapine fumarate,TABLET;ORAL,01/31/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020639s072lbl.pdf#page=49
seroquel xr,quetiapine fumarate,"TABLET, EXTENDED RELEASE;ORAL",01/28/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022047s046lbl.pdf#page=53
sertraline,sertraline hydrochloride,CAPSULE;ORAL,08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215133s001lbl.pdf#page=27
signifor,pasireotide diaspartate,SOLUTION;SUBCUTANEOUS,01/15/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200677s006lbl.pdf#page=15
siklos,hydroxyurea,TABLET;ORAL,11/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208843s004lbl.pdf#page=18
silenor,doxepin hydrochloride,TABLET;ORAL,10/29/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022036s006lbl.pdf#page=19
siliq,brodalumab,INJECTABLE;INJECTION,08/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761032s014lbl.pdf#page=14
simponi,golimumab,INJECTABLE; INJECTION,09/24/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125289s146lbl.pdf#page=38
simponi aria,golimumab,INJECTABLE; INJECTION,02/01/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125433s032lbl.pdf#page=34
sinequan,doxepin hydrochloride,CAPSULE;ORAL,07/14/2014,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089129.pdf
singulair,montelukast sodium,GRANULE;ORAL,02/22/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf#page=25"
singulair,montelukast sodium,TABLET;ORAL,02/22/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf#page=25"
singulair,montelukast sodium,"TABLET, CHEWABLE;ORAL",02/22/2021,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf#page=25"
sirturo,bedaquiline fumarate,TABLET;ORAL,06/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204384s017lbl.pdf#page=27
skyrizi,risankizumab-rzaa,INJECTABLE;SUBCUTANEOUS,06/18/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761262s001lbl.pdf#page=30
skyrizi,risankizumab-rzaa,INJECTABLE;INJECTION,06/18/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761105s018lbl.pdf#page=30
sodium oxybate,sodium oxybate,SOLUTION;ORAL,01/03/2022,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202090lbl.pdf#page=18
sohonos,paloverotene,CAPSULE;ORAL,08/16/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215559s000lbl.pdf#page=20
solaraze,diclofenac sodium,GEL;TOPICAL,11/14/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s024lbl.pdf#page=22
solaraze,diclofenac sodium,GEL;TOPICAL,04/28/2021,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501655.pdf
soliqua 100/33,insulin glargine; lixisenatide,SOLUTION;SUBCUTANEOUS,09/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208673s013lbl.pdf#page=29
soliris,eculizumab,INJECTABLE; IV (INFUSION),06/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125166s431lbl.pdf#page=40
soltamox,tamoxifen citrate,SOLUTION;ORAL,04/08/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf#page=36
sonata,zaleplon,CAPSULE;ORAL,08/18/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s016lbl.pdf#page=21
soriatane,acitretin,CAPSULE;ORAL,02/22/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019821s029lbl.pdf#page=30
sotret,isotretinoin,CAPSULE;ORAL,04/12/2012,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Sotret.pdf
sotyktu,deucravacitinib,TABLET;ORAL,09/09/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214958s000lbl.pdf#page=19
spevigo,spesolimab-sbzo,INJECTABLE;INTRAVENOUS,03/18/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761244s000lbl.pdf#page=11
spravato,esketamine hydrochloride,SPRAY;NASAL,10/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211243s012lbl.pdf#page=43
spritam,levetiracetam,"TABLET, FOR SUSPENSION;ORAL",06/14/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207958s023lbl.pdf#page=36
sprix,ketorolac tromethamine,"SPRAY, METERED;NASAL",11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022382s022lbl.pdf#page=22
stavzor,valproic acid,"CAPSULE, DELAYED RELEASE;ORAL",11/30/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022152s009lbl.pdf#page=42
steglatro,ertugliflozin,TABLET;ORAL,09/12/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209803s007lbl.pdf#page=25
steglujan,ertugliflozin; sitagliptin phosphate,TABLET;ORAL,09/12/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209805s016lbl.pdf#page=30
stelara,ustekinumab,INJECTABLE;INJECTION,03/18/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761044s009lbl.pdf#page=37
stelara,ustekinumab,INJECTABLE; INJECTION,03/18/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125261s158,761044s009lbl.pdf#page=36"
strattera,atomoxetine hydrochloride,CAPSULE;ORAL,01/06/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021411s050lbl.pdf#page=20
striverdi respimat,olodaterol hydrochloride,"SPRAY, METERED;INHALATION",05/29/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/striverdi respimatMedGuide2016.pdf
sublocade,buprenorphine,"SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS",09/22/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s018lbl.pdf#page=45
suboxone,buprenorphine hydrochloride; naloxone hydrochloride,"FILM;BUCCAL, SUBLINGUAL",06/17/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022410s046s047lbl.pdf#page=35
suboxone,buprenorphine hydrochloride; naloxone hydrochloride,TABLET;SUBLINGUAL,06/17/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020733s031s032lbl.pdf#page=32
subsys,fentanyl,SPRAY;SUBLINGUAL,12/03/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202788s023lbl.pdf#page=40
subutex,buprenorphine hydrochloride,TABLET;SUBLINGUAL,06/17/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020732s027s028lbl.pdf#page=29
suclear,magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate,SOLUTION;ORAL,08/15/2013,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203595s000lbl.pdf#page=13
suflave,polyethylene glycol 3350; sodium sulfate; potassium chloride; magnesium sulfate; sodium chloride,SOLUTION;ORAL,06/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215344s000lbl.pdf#page=14
sunosi,solriamfetol hydrochloride,TABLET;ORAL,06/28/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211230s009lbl.pdf#page=23
supprelin la,histrelin acetate,IMPLANT;SUBCUTANEOUS,04/22/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022058s017lbl.pdf#page=20
suprep bowel prep kit,magnesium sulfate; potassium sulfate; sodium sulfate,SOLUTION;ORAL,08/05/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022372s013lbl.pdf#page=13
surmontil,trimipramine maleate,CAPSULE;ORAL,09/30/2014,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016792s037lbl.pdf#page=12
sustol,granisetron,"INJECTION, EXTENDED RELEASE;SUBCUTANEOUS",05/25/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022445s010lbl.pdf#page=17
sutab,magnesium sulfate; potassium chloride; sodium sulfate,TABLET;ORAL,10/24/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213135s004lbl.pdf#page=15
sutent,sunitinib malate,CAPSULE;ORAL,08/30/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021938s039lbledt.pdf#page=34
sylatron,peginterferon alfa-2b,VIAL,12/21/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5312lbl.pdf#page=13
symbyax,fluoxetine hydrochloride; olanzapine,CAPSULE;ORAL,08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021520s055lbl.pdf#page=42
symlin,pramlintide acetate,INJECTABLE;SUBCUTANEOUS,12/18/2019,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089141.pdf
sympazan,clobazam,FILM;ORAL,03/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210833s004lbl.pdf#page=26
symproic,naldemedine tosylate,TABLET;ORAL,01/24/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208854s002lbl.pdf#page=13
synalgos-dc,aspirin; caffeine; dihydrocodeine bitartrate,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011483s037lbl.pdf
synarel,nafarelin acetate,"SPRAY, METERED;NASAL",01/31/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019886s039lbl.pdf#page=28
synjardy,empagliflozin; metformin hydrochloride,TABLET;ORAL,10/30/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206111s042,208658s028lbl.pdf#page=44"
synjardy xr,empagliflozin; metformin hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",10/30/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206111s042,208658s028lbl.pdf#page=44"
synribo,omacetaxine mepesuccinate,POWDER;SUBCUTANEOUS,05/12/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203585Orig1s008lbl.pdf#page=18
tafinlar,dabrafenib mesylate,CAPSULE;ORAL,03/29/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202806s027lbl.pdf#page=46
tafinlar,dabrafenib,TABLET;ORAL,03/29/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217514s000lbl.pdf#page=46
taltz,ixekizumab,INJECTABLE;INJECTION,07/27/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125521s024lbl.pdf#page=21
talvey,talquetamab-tgvs,INJECTABLE; SUBCUTANEOUS,08/09/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761342s000lbl.pdf#page=30
tanzeum,albiglutide,INJECTABLE;INJECTION,12/20/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125431s019lbl.pdf#page=36
targiniq,naloxone hydrochloride; oxycodone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",09/18/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205777s010s011lbl.pdf#page=47
tasigna,nilotinib hydrochloride,CAPSULE;ORAL,02/08/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022068s035s036lbl.pdf#page=36
tavneos,avacopan,CAPSULE;ORAL,06/03/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214487s000lbl.pdf#page=17
tazverik,tazemetostat hydrobromide,TABLET;ORAL,11/16/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211723s004lbl.pdf#page=17
tazverik,tazemetostat hydrobromide,TABLET;ORAL,06/18/2020,http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213400s000lbl.pdf#page=17
tecentriq,atezolizumab,INJECTABLE;INJECTION,04/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761034s049s051lbl.pdf#page=62
tecentriq,atezolizumab,INJECTABLE; INJECTION,10/18/2016,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761041s000lbl.pdf#page=22
technivie,ombitasvir; paritaprevir; ritonavir,TABLET;ORAL,12/06/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207931s013lbl.pdf#page=39
tecvayli,teclistamab-cqyv,INJECTABLE; SUBCUTANEOUS,11/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761291s009lbl.pdf#page=28
tegretol,carbamazepine,SUSPENSION;ORAL,09/13/2023,http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf#page=19
tegretol,carbamazepine,"TABLET, CHEWABLE;ORAL",03/20/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19
tegretol,carbamazepine,TABLET;ORAL,09/13/2023,http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf#page=19
tegretol-xr,carbamazepine,"TABLET, EXTENDED RELEASE;ORAL",09/13/2023,http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016608s121_018927s60_020234s054lbl.pdf#page=19
tegsedi,inotersen sodium,SOLUTION;SUBCUTANEOUS,01/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211172s010lbl.pdf#page=28
testim,testosterone,GEL;TRANSDERMAL,08/20/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021454s030s031lbl.pdf#page=21
testosterone,testosterone,GEL;TRANSDERMAL,10/25/2016,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202763s000mg.pdf
testosterone cypionate injection,testosterone cypionate,INJECTABLE;INTRAMUSCULAR,02/01/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216318Orig1s002lbl.pdf#page=14
thalomid,thalidomide,CAPSULE;ORAL,03/24/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020785s071lbl.pdf#page=21
tibsovo,ivosidenib,TABLET;ORAL,10/24/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211192s011lbl.pdf#page=38
tikosyn,dofetilide,CAPSULE;ORAL,08/08/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020931s017lbl.pdf#page=27
tivdak,tisotumab vedotin-tftv,INJECTABLE;INJECTION,04/29/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761208s005lbl.pdf#page=21
tivorbex,indomethacin,CAPSULE;ORAL,04/28/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204768s008lbl.pdf#page=25
tofidence,tocilizumab-bavi,INJECTABLE;INTRAVENOUS,12/03/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s004lbl.pdf#page=55
tofranil,imipramine hydrochloride,TABLET;ORAL,06/29/2017,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3"
tofranil-pm,imipramine pamoate,CAPSULE;ORAL,07/28/2014,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf
tolectin,tolmetin sodium,TABLET;ORAL,01/22/2008,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf
tolectin 600,tolmetin sodium,TABLET;ORAL,01/22/2008,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf
tolectin ds,tolmetin sodium,CAPSULE;ORAL,01/22/2008,http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf
topamax,topiramate,TABLET;ORAL,05/03/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56"
topamax,topiramate,CAPSULE;ORAL,05/03/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56"
topamax sprinkle,topiramate,CAPSULE;ORAL,05/03/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56"
toradol,ketorolac tromethamine,TABLET;ORAL,03/26/2013,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf#page=23
tracleer,bosentan,TABLET;ORAL,02/08/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021290s039,209279s005lbl.pdf#page=30"
tracleer,bosentan,"TABLET, FOR SUSPENSION;ORAL",02/08/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021290s039,209279s005lbl.pdf#page=30"
tradjenta,linagliptin,TABLET;ORAL,06/20/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201280s027lbl.pdf#page=16
tranxene,clorazepate dipotassium,CAPSULE;ORAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14
tranxene,clorazepate dipotassium,TABLET;ORAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14
tranxene sd,clorazepate dipotassium,TABLET;ORAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14
trazodone hydrochloride,trazodone hydrochloride,TABLET;ORAL,04/20/2020,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/071196s062lbl.pdf#page=3
trelegy ellipta,fluticasone furoate; umeclidinium bromide; vilanterol trifenatate,POWDER;INHALATION,06/02/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209482s000lbl.pdf#page=33
tremfya,guselkumab,INJECTABLE;INJECTION,06/29/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761061s009lbl.pdf#page=15
treximet,naproxen sodium; sumatriptan succinate,TABLET;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021926s019lbl.pdf#page=32
tridione,trimethadione,SOLUTION;ORAL,06/07/2016,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf
tridione,trimethadione,CAPSULE;ORAL,06/07/2016,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf
tridione,trimethadione,TABLET;ORAL,06/07/2016,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf
trijardy xr,empagliflozin; linagliptin; metformin hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",10/30/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212614s020lbl.pdf#page=44
trileptal,oxcarbazepine,SUSPENSION;ORAL,01/04/2019,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021014s042,021285s035lbl.pdf#page=26"
trileptal,oxcarbazepine,TABLET;ORAL,01/04/2019,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021014s042,021285s035lbl.pdf#page=26"
trintellix,vortioxetine hydrobromide,TABLET;ORAL,08/23/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204447s026lbl.pdf#page=33
triptodur kit,triptorelin pamoate,"FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR",12/07/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208956s010lbl.pdf#page=12
triumeq,abacavir sulfate; dolutegravir sodium; lamivudine,TABLET;ORAL,04/18/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205551s31,215413s02lbl.pdf#page=56"
triumeq pd,abacavir sulfate; dolutegravir sodium; lamivudine,SUSPENSION;ORAL,04/18/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205551s31,215413s02lbl.pdf#page=56"
trizivir,abacavir sulfate; lamivudine; zidovudine,TABLET;ORAL,02/17/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021205s038lbl.pdf#page=34
trokendi xr,topiramate,"CAPSULE, EXTENDED RELEASE;ORAL",01/04/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201635s030lbl.pdf#page=52
troxyca er,naltrexone hydrochloride; oxycodone hydrochloride,"CAPSULE, EXTENDED RELEASE;ORAL",05/26/2017,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207621s004lbl.pdf#page=32
trudhesa,dihydroergotamine mesylate,"SPRAY, METERED;NASAL",09/02/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213436s000lbl.pdf#page=22
trulance,plecanatide,TABLET;ORAL,04/13/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s011lbl.pdf#page=15
trulicity,dulaglutide,INJECTABLE;INJECTION,11/17/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125469s051lbl.pdf#page=16
truvada,emtricitabine; tenofovir disoproxil fumarate,TABLET;ORAL,04/29/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021752Orig1s063lbl.pdf#page=35
truxima,rituximab-abbs,INJECTABLE;INJECTION,02/04/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761088s018lbl.pdf#page=49
turalio,pexidartinib hydrochloride,CAPSULE;ORAL,11/16/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211810s012lbl.pdf#page=20
tussionex pennkinetic,chlorpheniramine polistirex; hydrocodone polistirex,"SUSPENSION, EXTENDED RELEASE;ORAL",06/28/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019111s022lbl.pdf#page=25
tuxarin er,chlorpheniramine maleate; codeine phosphate,"TABLET, EXTENDED RELEASE;ORAL",12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206323s008lbl.pdf#page=27
tuzistra xr,chlorpheniramine polistirex; codeine polistirex,"SUSPENSION, EXTENDED RELEASE;ORAL",12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207768s013lbl.pdf#page=27
tyenne,tocilizumab--aazg,INJECTABLE;SUBCUTANEOUS,12/03/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761275s011lbl.pdf#page=46
tymlos,abaloparatide,SOLUTION;SUBCUTANEOUS,12/21/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208743s009lbl.pdf#page=18
tysabri,natalizumab,VIAL; SINGLE-USE,10/30/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125104s976s979lbl.pdf#page=32
tyzeka,telbivudine,TABLET;ORAL,12/27/2018,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19"
tyzeka,telbivudine,SOLUTION;ORAL,12/27/2018,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19"
ukoniq,umbralisib tosylate,TABLET;ORAL,02/05/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213176s000lbl.pdf#page=19
uloric,febuxostat,TABLET;ORAL,04/17/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021856s015lbl.pdf#page=19
ultomiris,ravulizumab-cwvz,INJECTABLE;INJECTION,06/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761108s023lbl.pdf#page=41
ultracet,acetaminophen; tramadol hydrochloride,TABLET;ORAL,02/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021123s015lbl.pdf#page=46
ultram,tramadol hydrochloride,TABLET;ORAL,02/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020281s040lbl.pdf#page=42
ultram er,tramadol hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",08/29/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf#page=36
uplizna,inebilizumab-cdon,INJECTABLE;INJECTION,06/11/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761142s000lbl.pdf#page=17
valchlor,mechlorethamine hydrochloride,GEL;TOPICAL,05/01/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202317s009lbl.pdf#page=10
valium,diazepam,TABLET;ORAL,03/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263Orig1s100lbl.pdf#page=19
valtoco,diazepam,SPRAY;NASAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211635s008lbl.pdf#page=24
vanflyta,quizartinib,TABLET;ORAL,06/25/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216993s000lbl.pdf#page=20
vantrela er,hydrocodone bitartrate,"TABLET, EXTENDED RELEASE;ORAL",05/26/2017,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207975s000lbl.pdf#page=39
velsipity,etrasimod arganine,TABLET;ORAL,06/05/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216956s000lbl.pdf#page=24
venbysi xr,venlafaxine besylate,"TABLET, EXTENDED RELEASE; ORAL",08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215429s001lbl.pdf#page=33
venclexta,venetoclax,TABLET;ORAL,06/15/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208573s026lbl.pdf#page=54
venlafaxine hydrochloride,venlafaxine hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022104s023lbl.pdf#page=35
veopoz,pozelimab-bbfg,"INJECTABLE;INTRAVENOUS, SUBCUTANEOUS",08/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761339s000lbl.pdf#page=16
verquvo,vericiguat,TABLET;ORAL,05/10/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214377s002lbl.pdf#page=16
vibativ,telavancin,INJECTABLE; INJECTION,06/21/2013,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf
vibativ,telavancin hydrochloride,POWDER;INTRAVENOUS,07/07/2020,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf
viberzi,eluxadoline,TABLET;ORAL,06/17/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206940s007lbl.pdf#page=20
vicoprofen,hydrocodone bitartrate; ibuprofen,TABLET;ORAL,12/16/2016,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020716s012s013s014s015s016lbl.pdf#page=36
victoza,liraglutide recombinant,SOLUTION;SUBCUTANEOUS,07/05/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022341s039lbl.pdf#page=31
victrelis,boceprevir,CAPSULE;ORAL,01/30/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202258MG.pdf#page=27
videx,didanosine,FOR SOLUTION;ORAL,12/17/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020156s054lbl.pdf#page=34
videx ec,didanosine,"CAPSULE, DELAYED REL PELLETS;ORAL",12/17/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021183s029lbl.pdf#page=33
viekira pak (copackaged),"dasabuvir sodium; ombitasvir, paritaprevir, ritonavir",TABLET;ORAL,12/06/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206619s020lbl.pdf#page=49
viekira xr,dasabuvir sodium; ombitasvir; paritaprevir; ritonavir,"TABLET, EXTENDED RELEASE;ORAL",12/06/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208624s008lbl.pdf#page=49
viibryd,vilazodone hydrochloride,TABLET;ORAL,04/19/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022567s024lbl.pdf#page=17
vimovo,esomeprazole magnesium; naproxen,"TABLET, DELAYED RELEASE;ORAL",11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022511s030lbl.pdf#page=40
vimpat,lacosamide,TABLET;ORAL,10/16/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31"
vimpat,lacosamide,SOLUTION;INTRAVENOUS,10/16/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31"
vimpat,lacosamide,SOLUTION;ORAL,10/16/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31"
viokace,pancrelipase (amylase;lipase;protease),TABLET;ORAL,02/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022542s007lbl.pdf#page=12
viramune,nevirapine,SUSPENSION;ORAL,06/10/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020636s052,020933s043lbl.pdf#page=19"
viramune,nevirapine,TABLET;ORAL,06/10/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020636s052,020933s043lbl.pdf#page=19"
viramune xr,nevirapine,"TABLET, EXTENDED RELEASE;ORAL",06/10/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201152s014lbl.pdf#page=18
visicol,"sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate",TABLET;ORAL,03/07/2013,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021097s016lbl.pdf#page=11
vituz,chlorpheniramine maleate; hydrocodone bitartrate,SOLUTION;ORAL,06/28/2018,http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204307s004lbl.pdf#page=25
vivactil,protriptyline hydrochloride,TABLET;ORAL,07/17/2014,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Vivactil.pdf
vivitrol,naltrexone,"FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR",09/30/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021897s052lbl.pdf#page=33
vivlodex,meloxicam,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/207233s005lbl.pdf#page=24
vogelxo,testosterone,GEL;TRANSDERMAL,04/30/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf#page=23
vogelxo,testosterone,"GEL, METERED;TRANSDERMAL",04/30/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf#page=23
voltaren,diclofenac sodium,"TABLET, DELAYED RELEASE;ORAL",04/28/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019201s048lbl.pdf#page=18
voltaren arthritis pain,diclofenac sodium,GEL;TOPICAL,11/29/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022122s011lbl.pdf#page=22
voltaren-xr,diclofenac sodium,"TABLET, EXTENDED RELEASE;ORAL",04/28/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf#page=18
votrient,pazopanib hydrochloride,TABLET;ORAL,01/25/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022465s031s032lbl.pdf#page=27
vraylar,cariprazine hydrochloride,CAPSULE;ORAL,11/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204370s012lbl.pdf#page=46
vyvanse,lisdexamfetamine dimesylate,CAPSULE;ORAL,10/13/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021977s050,208510s007lbl.pdf#page=38"
vyvanse,lisdexamfetamine dimesylate,"TABLET, CHEWABLE;ORAL",10/13/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021977s050,208510s007lbl.pdf#page=38"
wegovy,semaglutide,SOLUTION;SUBCUTANEOUS,11/27/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s015lbl.pdf#page=35
welireg,belzutifan,TABLET;ORAL,02/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215383s006lbl.pdf#page=17
wellbutrin,bupropion hydrochloride,TABLET;ORAL,05/07/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018644s057lbl.pdf#page=32
wellbutrin sr,bupropion hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",05/07/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020358s064lbl.pdf#page=34
wellbutrin xl,bupropion hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",05/07/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021515s044lbl.pdf#page=29
wezlana,ustekinumab-auub,"INJECTABLE;SUBCUTANEOUS, INTRAVENOUS",10/31/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761285s000,761331s000lbl.pdf#page=36"
wezlana,ustekinumab-auub,"INJECTABLE;SUBCUTANEOUS, INTRAVENOUS",10/31/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761285s000,761331s000lbl.pdf#page=36"
xalkori,crizotinib,CAPSULE;ORAL,09/07/2023,http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202570s036lbl.pdf#page=46
xanax,alprazolam,TABLET;ORAL,01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf#page=22
xanax xr,alprazolam,"TABLET, EXTENDED RELEASE;ORAL",01/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021434s022lbl.pdf#page=23
xarelto,rivaroxaban,FOR SUSPENSION;ORAL,02/08/2023,http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215859s000lbl.pdf#page=77
xarelto,rivaroxaban,TABLET;ORAL,03/01/2022,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406s039,202439s038lbl.pdf#page=77"
xarelto,rivaroxaban,TABLET;ORAL,02/08/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406s039,202439s038lbl.pdf#page=77"
xartemis xr,acetaminophen; oxycodone hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",09/18/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204031s004s005lbl.pdf#page=34
xcopri,cenobamate,TABLET;ORAL,04/05/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212839s006s007lbl.pdf#page=25
xeljanz,tofacitinib citrate,SOLUTION;ORAL,09/27/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203214s036,208246s023,213082s008lbl.pdf#page=65"
xeljanz,tofacitinib citrate,TABLET;ORAL,09/27/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203214s036,208246s023,213082s008lbl.pdf#page=65"
xeljanz xr,tofacitinib citrate,"TABLET, EXTENDED RELEASE;ORAL",09/27/2024,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203214s036,208246s023,213082s008lbl.pdf#page=65"
xelstrym,dextroamphetamine,SYSTEM;TRANSDERMAL,10/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215401s008lbl.pdf#page=28
xenazine,tetrabenazine,TABLET;ORAL,09/13/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf#page=24
xeomin,incobotulinumtoxina,INJECTABLE;INJECTION,09/08/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125360s097lbl.pdf#page=23
xiaflex,collagenase clostridium histolyticum,SOLUTION; INJECTION,07/12/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125338s111lbl.pdf#page=33
xigduo xr,dapagliflozin; metformin hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",06/12/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205649s021lbl.pdf#page=59
xolair,omalizumab,VIAL,02/16/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103976s5242lbl.pdf#page=37
xospata,gilteritinib fumarate,TABLET;ORAL,01/12/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211349s003lbl.pdf#page=18
xpovio,selinexor,TABLET;ORAL,07/15/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212306s010lbl.pdf#page=31
xtampza er,oxycodone,"CAPSULE, EXTENDED RELEASE;ORAL",12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208090s021lbl.pdf#page=40
xtrelus,hydrocodone bitartrate;guaifenesin,TABLET;ORAL,12/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208085s002lbl.pdf#page=22
xultophy 100/3.6,insulin degludec; liraglutide,SOLUTION;SUBCUTANEOUS,07/10/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208583s021lbl.pdf#page=42
xyosted (autoinjector),testosterone enanthate,SOLUTION;SUBCUTANEOUS,11/19/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209863s000lbl.pdf#page=16
xyrem,sodium oxybate,SOLUTION;ORAL,05/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021196s042lbl.pdf#page=26
xywav,calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate,SOLUTION;ORAL,05/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212690s011lbl.pdf#page=29
yervoy,ipilimumab,INJECTABLE; INJECTION,02/15/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125377s129lbl.pdf#page=72
yesintek,ustekinumab-kfce,"INJECTABLE;INTRAVENOUS, SUBCUTANEOUS",Invalid date,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761406s000lbl.pdf#page=37
yosprala,aspirin; omeprazole,"TABLET, DELAYED RELEASE;ORAL",11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205103s010lbl.pdf#page=29
yuflyma,adalimumab-aaty,INJECTABLE;SUBCUTANEOUS,08/16/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761219s011lbl.pdf#page=43
yusimry,adalimumab-aqvh,INJECTABLE;INJECTION,09/13/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761216s004lbl.pdf#page=56
zarontin,ethosuximide,CAPSULE;ORAL,10/28/2021,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/012380s034mg.pdf
zegerid,omeprazole; sodium bicarbonate,FOR SUSPENSION;ORAL,07/18/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021849s020,021636s025lbl.pdf#page=31"
zegerid,omeprazole; sodium bicarbonate,CAPSULE;ORAL,07/18/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021849s020,021636s025lbl.pdf#page=31"
zelboraf,vemurafenib,TABLET;ORAL,05/18/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202429s016lbl.pdf#page=21
zenpep,pancrelipase;lipase;protease;amylase,"CAPSULE, DELAYED RELEASE;ORAL",02/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022210s024lbl.pdf#page=14
zenpep,pancrelipase (amylase;lipase;protease),"CAPSULE, DELAYED RELEASE;ORAL",02/28/2024,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM180714.pdf
zeposia,ozanimod hydrochloride,CAPSULE;ORAL,06/05/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209899s006s009lbl.pdf#page=25
zerit,stavudine,FOR SOLUTION;ORAL,12/17/2018,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020412s041,020413s033lbl.pdf#page=29"
ziagen,abacavir sulfate,SOLUTION;ORAL,11/24/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020977s035,020978s038lbl.pdf#page=27"
zilbrysq,zilucoplan,INJECTABLE;SUBCUTANEOUS,04/26/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216834s000lbl.pdf#page=20
zinbryta,daclizumab,INJECTABLE;INJECTION,11/01/2017,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761029s001lbl.pdf#page=24
zipsor,diclofenac potassium,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022202s016lbl.pdf#page=24
zituvimet,"sitagliptin, metformin hydrochloride",TABLET;ORAL,11/03/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216743s000lbl.pdf#page=38
zituvio,sitagliptin,TABLET;ORAL,10/18/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211566s000lbl.pdf#page=33
zohydro er,hydrocodone bitartrate,"CAPSULE, EXTENDED RELEASE;ORAL",03/04/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202880s020lbl.pdf#page=30
zoloft,sertraline hydrochloride,CONCENTRATE;ORAL,08/18/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf#page=37"
zoloft,sertraline hydrochloride,TABLET;ORAL,08/18/2023,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf#page=37"
zolpidem tartrate,zolpidem tartrate,TABLET;ORAL,03/07/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Zolpidem.pdf
zolpidem tartrate capsules,zolpidem tartrate,CAPSULE;ORAL,05/09/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215721s000lbl.pdf#page=27
zolpimist,zolpidem tartrate,"SPRAY, METERED;ORAL",08/18/2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022196s012lbl.pdf#page=19
zonegran,zonisamide,CAPSULE;ORAL,04/13/2020,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020789s036lbl.pdf#page=25
zonisade,zonisamide,SUSPENSION;ORAL,07/15/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214273s000lbl.pdf#page=27
zontivity,vorapaxar sulfate,TABLET;ORAL,11/07/2019,http://www.fda.gov/downloads/Drugs/DrugSafety/UCM447698.pdf
zortress,everolimus,TABLET;ORAL,02/28/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021560s033lbl.pdf#page=31
zorvolex,diclofenac,CAPSULE;ORAL,11/21/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204592s014lbl.pdf#page=26
ztalmy,ganaxolone,SUSPENSION;ORAL,06/21/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215904s003s004lbl.pdf#page=16
zubsolv,buprenorphine hydrochloride; naloxone hydrochloride,TABLET;SUBLINGUAL,03/20/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204242s027lbl.pdf#page=19
zulresso,brexanolone,SOLUTION;INTRAVENOUS,10/17/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211371s007lbl.pdf#page=20
zurampic,lesinurad,TABLET;ORAL,08/04/2016,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf#page=17
zurzuvae,zuranolone,CAPSULE;ORAL,08/04/2023,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369Orig2s000Corrected_lbl.pdf#page=22
zutripro,chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride,SOLUTION;ORAL,06/28/2018,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022439s010lbl.pdf#page=28
zyban,bupropion hydrochloride,"TABLET, EXTENDED RELEASE;ORAL",03/09/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020711s052lbl.pdf#page=38
zydelig,idelalisib,TABLET;ORAL,07/06/2022,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205858s016lbl.pdf#page=25
zymfentra,infliximab-dyyb,INJECTABLE;SUBCUTANEOUS,02/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761358s000lbl.pdf#page=30
zynyz,retifanlimab-dlwr,INJECTABLE;INTRAVENOUS,04/22/2024,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761334s000lbl.pdf#page=18
zyprexa,olanzapine,TABLET;ORAL,04/23/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"
zyprexa,olanzapine,INJECTABLE;INTRAMUSCULAR,04/23/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"
zyprexa relprevv,olanzapine pamoate,"SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR",04/28/2021,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022173s036lbl.pdf#page=29
zyprexa zydis,olanzapine,"TABLET, ORALLY DISINTEGRATING;ORAL",04/23/2020,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"
